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INTRODUCTION 
Human reproduction is a sophisticated matter and can be affected by many 
factors, such as health status, accompanying diseases, genetic background, en-
vironment, and lifestyle. According to the World Health Organization, over 10% 
of females in a stable relationship are suffering from involuntary infertility/ 
subfertility worldwide. The central process of female fertility – the menstrual 
cycle – is a complex process that is regulated by various factors, results in the 
maturation and release of oocytes, and structural changes in the inner uterine 
lining (endometrial tissue) in anticipation of the implanting embryo. The 
embryo implantation process requires precise regulation, right timing, and co-
operation between the endometrium and the embryo, otherwise, implantation 
fails. The endometrium is most receptive to the embryo during a relatively short 
period of time, called the window of implantation. To reach this receptive state, 
the orchestrated coordination of many factors, including different ‘omics’ data 
layers is needed. The main ‘omics’ disciplines include transcriptomics and 
methylomics. Perhaps the most well-known is transcriptomics, which is as-
sociated with transcription and can be studied using gene expression array or 
RNA sequencing technologies. On the other hand, methylomics deals with DNA 
methylation processes and related mechanisms, and also uses arrays and 
sequencing as research tools. Usually, knowledge of one ‘omics’ layer is not 
enough to see the whole picture, as all the processes are interconnected, where 
DNA methylation regulates gene expression and vice versa, or transcription of 
one RNA is regulated by another RNA and so on. Thus, the integration of seve-
ral ‘omics’ data layers is necessary for a better understanding of complex pro-
cesses, such as endometrial receptivity. 
The current thesis is focused on integrating some of the ‘omics’ layers in the 
context of healthy endometrium during the transition from pre-receptive to 
receptive states using bioinformatic tools. In the literature overview part, I touch 
upon the mechanisms underlying the female menstrual cycle and embryo 
implantation. Next, I take a look at research methods used in obtaining and 
handling transcription and methylation datasets, tell about the pros and cons of 
these methods, and discuss the possible problems that could arise during data 
handling. Also, I give an overview of how ‘omics’ data has been used in the 
context of female reproductive studies.  
In the experimental part, I show the integration between whole-tissue and 
cell-type-specific RNA sequencing datasets, introduce whole tissue deconvo-
lution and present the results we obtained. Secondly, I evaluate predicted gene-
microRNA (miRNA) interactions through the integration of expression datasets 
of miRNAs and their associated target genes. And finally, I present an analysis 
of methylation data from endometrial tissue, obtained with Infinium Human 
Methylation 450K BeadChip, and its correlation with gene expression. The 
dataset used in these studies is unique, as endometrial whole-tissue methylation, 
messenger RNA (mRNA) and miRNA expression data originate from the same 
13 
individuals/samples, and additionally represent paired sampling i.e. both pre-
receptive and receptive samples were collected from the same individual within 
one menstrual cycle.  
The current thesis focuses on only pairwise integration of data layers; how-
ever, additional layers would provide an even better understanding of processes 
underlying endometrial receptivity. Hopefully, our studies encourage other 
researchers in the field to use more data layers in further endometrial studies. 
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1. LITERATURE REVIEW 
1.1. Journey from past to nowadays 
Our understanding of the female reproductive system and related processes has 
evolved in time. The oldest known description of the ovary was made by 
ancient Greeks in the first century AD. Ancient Greek physician and philo-
sopher Galen described female uterus as a male penis and testicles that are 
placed inside the body. While in middle ages master Nicolaus described it as an 
organ that is hollow and villous inside and smooth outside, is divided into seven 
compartments and has two openings. The knowledge about female anatomy was 
broadened by Leonardo da Vinci with his precise drawings and descriptions 
(Figure 1). Sadly, da Vinci also described the female reproductive system through 
the male reproductive system. In the 17th and 18th centuries, the female and male 
reproductive systems were finally separated and viewed as distinct ones. 
 
 
Figure 1: Leonardo da Vinci – Studies of the Foetus in the Womb (Da Vinci, 1510). 
Copyright: The Royal Collection © Her Majesty Queen Elizabeth II. Source: Wikimedia 
commons. 
  
 
? 
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In parallel to an increased understanding of female reproduction and fertility, 
new scientific methods evolved. It could be said that the journey to the micro-
world started in the late 16th century with the invention of the first microscopes, 
when the microscopic breakthrough was made by Antonie van Leeuwenhoek in 
the 1670s. That resulted in the discovery of the mammalian egg cell by C.E. von 
Baer in 1826/27 (Von Baer, 1827), description of the human egg cell by Edgar 
Allen in 1928/29 (Pratt et al., 1929), and observation of the fertilization process 
(fusion of egg and sperm) by Oskar Hertwig in 1876 (Hertwig, 1876). The start 
of the genetics era in the second half of the 19th century, with the trait inheri-
tance studies on garden peas by Gregor Mendel (Mendel, 1865) and the first 
discovery of nucleic acids (Miescher, 1871) moved the female reproduction 
studies to a molecular level, making the understanding of things even more 
complex. In the 20th century, genetics and associated methodology evolved 
rapidly, resulting in the discovery of the DNA structure in 1953 (Watson and 
Crick, 1953) and invention of the first sequencing method in 1970, which was 
further adapted and improved by Frederick Sanger (Wu, 1994). The new metho-
dologies contributed to rapid progress in the field of reproductive studies, 
resulting in first attempts in in vitro fertilization (IVF) in the late 60s, and in the 
birth of the first IVF child in 1978 (Bates and Bowling, 2013). Since then the 
understanding of various aspects of human reproduction has improved and IVF 
is currently a relatively common practice. For example, according to the 
Estonian National Institute for Health Development, in Estonia, nearly 3% of 
newborns were conceived via IVF (Tervise Arengu Instituut 2015a, 2016b).  
The RNA distinguishing from DNA (Allen, 1941) and RNA sequencing 
(Min Jou et al., 1972), invention of the polymerase chain reaction (PCR) and 
PCR based methods set the stage for a whole-genome sequencing boom and 
bloom of ‘omics’ studies. Nowadays, a full range of ‘omics’ studies, such as 
genomics, transcriptomics, proteomics, metabolomics and more, lead to new 
research directions where these layers are integrated to provide a bigger and 
more coherent picture of biological processes (and process malfunctions in 
diseases) taking place within a single organism, tissue or even a single cell. 
Such deep insight into biological processes, where all these different ‘omics’ 
levels are working in orchestrated harmony, gives a possibility to manage repro-
duction and fertility problems on a personal level, improving diagnostics and 
treatment outcomes and thus leading to a healthier and happier society.2 
 
 
                                                 
2  Historical overview is mainly based on books “A History of the Life Sciences” by 
Magner L.(Magner, 2002) and “Making sex: body and gender from the Greeks to Freud” by 
Laqueur T. (Laqueur, 2003); and web-materials “A history of the male and female genitalia” 
by Findlen P. (Findlen, 1998) 
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1.2. Overview of female reproduction 
The female reproductive system consists of external and internal organs. The 
outer part is called vulva and forms female external genitalia, while the inner 
part is divided into the vagina, uterus, fallopian tubes and ovaries. The vagina is 
a fibromuscular tubular structure connecting the vulva and the uterus. The 
uterus is a muscular organ that nourishes and supports the growing embryo, and 
anatomically includes a body and cervix, where the cervix is a narrow part of 
the uterus that forms a connection with the vagina (Figure 2). The uterine body 
has three major layers: outer serous membrane or perimetrium, the middle 
muscular layer (myometrium), and inner uterine lining – endometrium, which 
plays an important role during embryo implantation, and consists of basal and 
functional layers. The fallopian tubes connect the uterus with the ovaries and 
facilitate gamete and embryo transport. The ovaries hold the female ovarian 
reserve, are the site of folliculogenesis and also a source of sex hormones 
governing the maturation of the endometrium.3 
The newborn female already has 1–2 million primary oocytes (Himelstein-
Braw et al., 1976), which decrease in number with aging, and by puberty, there 
are about 300–500 thousand follicles left (Richardson et al., 1987). During the 
reproductive lifespan, only 400–500 oocytes complete the ovulation process 
(Richardson et al., 1987), and only one egg is usually released from the ovary 
each month. At puberty, the hypothalamus starts producing gonadotropin-
releasing hormone (GnRH) which signals the pituitary gland to release 
gonadotropins, luteinizing (LH) and follicle-stimulating hormones (FSH). The 
increasing levels of gonadotropins stimulate the ovaries to produce steroid 
hormones – progesterone and estrogen, which are important menstrual cycle 
regulators (Bates and Bowling, 2013). Menarche, that on average takes place at 
the age of 13, indicates the start of the female reproductive period and the 
beginning of a series of menstrual cycles. The cycle series last until menopause, 
which usually starts at the age of 50, and indicates the end of the reproductive 
period. The average menstrual cycle is 28 days long and is usually divided 
according to ovarian/follicle state to follicular and luteal phases, or by the 
endometrial state to proliferative and secretory phases (Bates and Bowling, 
2013; OpenStax, 2016). Ovulation indicates the transition from the follicular to 
the luteal phase, and also from the proliferative to the secretory phase. After 
ovulation, if the oocyte is fertilized, it starts rapid division and on the 4th – 5th 
day after fertilization transforms into a blastocyst. The blastocyst enters the 
uterine cavity and through communicating with the endometrium using different 
factors – for example, extracellular vesicles – attaches to the best area suitable 
for implantation and later invades the endometrium, thus establishing a 
                                                 
3 Female reproductive system anatomy description is based on “Handbook of Clinical 
Neurology” book part “Anatomy and physiology of genital organs – women” by Graziottin 
and Gambini (Graziottin and Gambini, 2015); “Physiology, Female Reproduction” publication 
by Rosner and Sarao (Rosner and Sarao, 2019); and “Anatomy and Physiology” web-book part 
“Anatomy and Physiology of the Female Reproductive System” (OpenStax, 2016). 
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pregnancy. If the oocyte is not fertilized on time, the uterine lining and un-
fertilized egg are shed via menstrual bleeding.4 
 
 
Figure 2. The female reproductive tract. The female reproductive tract includes the 
vagina, uterus, fallopian tubes and ovaries. Cervix is the junction between the uterus 
and vagina. Ovaries contain growing follicles, which are released after maturation 
during ovulation into the abdominal cavity. The fallopian tubes have filaments 
(fimbriae) attached to the ends (infundibulum) that catch the released oocytes and guide 
them into the tubes. The uterus consists of three tissue layers: outer membrane – peri-
metrium, muscular layer – myometrium and the inner uterine lining, which is partially 
shed during menstruation – the endometrium. The endometrium is divided into basal 
(cell source for the functional layer) and functional layer (is shed during menstruation). 
The functional layer grows and matures during the menstrual cycle, developing glands 
and a capillary network (maximized: endometrium in late proliferative – early secretory 
phase). Drawn by Anton Kukuškin. 
 
 
There are many reasons why human reproduction could fail in the early stages. 
Some of the failures occur because of problems with sperm, egg or embryo 
quality; problems with endometrial maturation or implantation timing; embryo-
endometrium communication failure; various diseases – for instance, endo-
metriosis (Houshdaran et al., 2016; Sampson, 1927; Sanchez et al., 2014), poly-
cystic ovary syndrome (PCOS), premature ovarian insufficiency, and recurrent 
pregnancy loss (RPL) (Lucas et al., 2016). When women fail to get pregnant 
                                                 
4  Description of the menstrual cycle and its related processes are mainly based on review 
publication by Bates and Bowling (Bates and Bowling, 2013) and “Anatomy and Physio-
logy” web-book part “Anatomy and Physiology of the Female Reproductive System” (Open-
Stax, 2016). 
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within one year of regular intercourse, infertility is diagnosed and medical 
actions will follow. First of all, the cause is determined, and then a proper 
treatment is chosen depending on the cause of infertility. There are several 
infertility treatments available, such as intrauterine insemination and IVF. If 
three or more IVF cycles fail, in which one or two morphologically high-quality 
embryos are transferred during each cycle, repeated implantation failure (RIF) 
is diagnosed (Koot et al., 2016; Ruiz-Alonso et al., 2013). Besides, fertility 
could be influenced by physiological factors, such as genetics, or by lifestyle 
factors (smoking), or infections by viruses or bacteria (Damario, 2014). Likely, 
a better understanding of the normal reproductive processes will also help to 
solve infertility issues.  
To better understand the processes underlying what is collectively known as 
“female fertility”, we will now look at different physiological factors that are 
critical for maintaining female reproductive potential.  
 
 
1.3. Menstrual cycle 
The menstrual cycle is the process lasting from the first day of menstrual 
bleeding to the first menstruation day of the next cycle and is controlled by 
hormones produced by the hypothalamus, pituitary gland and ovaries (Figure 3) 
(Reed and Carr, 2015). The average cycle length in humans varies from 25 to 30 
(up to 34) days with a median duration of 28 days. The menstrual cycle length is 
relatively stable in healthy women at age 20–40 years, and varies greatly within 
the first 5–7 years after menarche and 6–8 years before menopause (Sherman 
and Korenman, 1975). Menstrual bleeding usually lasts 3–6 days in 80% of 
women (Mihm et al., 2011; Reed and Carr, 2015). The luteal phase is usually 14 
days long (Rosner and Sarao, 2019), but may vary from 7 to 19 days, while the 
length of the follicular phase varies more: from 10 to 23 days, and is the main 
determinant of menstrual cycle length. 
 
 
1.3.1. Regulation of menstrual cycle 
The menstrual cycle starts with the first day of bleeding, which is initiated with 
progesterone withdrawal (Figure 3. Steroid hormones) (Mihm et al., 2011; Reed 
and Carr, 2015) associated with the degenerating corpus luteum from the 
previous cycle. At the same time, the cohort of growing follicles is recruited 
(Figure 3. Gonadotropins) (Reed and Carr, 2015; Sherman and Korenman, 
1975). The follicle theca cells (outer layer) bind LH and as a result start andro-
gen production, while follicle granulosa cells (inner layer) bind FSH and as a 
result convert androgen to estrogen (Bates and Bowling, 2013), thus decreasing 
FSH level by negative feedback and raising estrogen levels. As a response to 
estrogen, endometrium starts growing and proliferating (Figure 3. Endometrial 
cycle) (Gómez et al., 2015; Nair and Taylor, 2010). LH level starts rising by the 
mid-follicular phase as a positive response to increased estrogen levels. The 
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FSH level reaches its minimum the day before ovulation, and LH reaches its 
maximum level on ovulation day (day ~14 of a 28-day cycle) (Figure 3. 
Gonadotropins) (Reed and Carr, 2015). Beside FSH and LH, other components 
play an important role during the follicular phase, such as activins (Sherman 
and Korenman, 1975), insulin-like growth factor 1 and 2 (IGF1 and IGF2) (Di 
Pietro et al., 2013; Zhou et al., 1994), various protein kinases (Makieva et al., 
2018), and epidermal growth factor, which collectively assist oocyte develop-
ment and maturation, while the plasma proteins, pituitary hormones, steroids, 
and non-steroidal ovarian factors regulate microenvironment of the ovary 
(Mihm et al., 2011). Among others, miRNAs also play a regulatory role in folli-
cular selection and ovulation (Tesfaye et al., 2018). 
Ovulation occurs in about 10–12 hours after the LH peak initiated by the rise 
of estradiol produced by the preovulatory follicle (Pauerstein et al., 1978). As 
the beginning of surge occurs roughly 34 – 36 hours before ovulation, this is 
used to predict ovulation timing. The LH surge stimulates progesterone 
synthesis (Figure 3. Gonadotropins), where progesterone stabilizes endometrial 
lining and in the following secretory phase induces the transformation of 
endometrial epithelium and decidualization of stromal fibroblasts, inhibits LH 
and FSH, and initiates granulosa cell luteinization (Figure 3. Steroid hormones) 
(Bates and Bowling, 2013; Houshdaran et al., 2014). 
After ovulation, luteinized granulosa cells combine with theca-lutein cells 
forming corpus luteum (Figure 3. Ovarian cycle), that synthesizes progesterone 
and estrogen from cholesterol and prepares the endometrium for embryo im-
plantation (Gómez et al., 2015; Murphy, 2004; Nair and Taylor, 2010), inducing 
specific structural and functional changes in endometrial epithelial cells – that 
include plasma membrane (Murphy, 2004) and cytoskeleton modifications 
(Martín et al., 2000; Thie et al., 1995) – and also decidualization process in 
stromal cells (Irwin et al., 1989). In response to corpus luteum secretion, capil-
laries start the invasion of the granulosa cell layer (Riesewijk, 2003), and on the 
8th or 9th day after ovulation, vascularization achieves its peak (Figure 3. Endo-
metrial cycle). Corpus luteum lifespan depends on LH secretion, and if pregnancy 
does not occur, the tissue undergoes luteolysis and forms scar tissue (Figure 3. 
Ovarian cycle). The decline of corpus luteum starts on days 9 – 11 after ovulation 
and results in steroid hormone (including progesterone) concentration decrease. 
At the same time stroma is filled with immune cells like macrophages, T-cells and 
natural killer cells (King et al., 1989; Nair and Taylor, 2010). Long exposure to 
progesterone leads to endometrial tissue thinning and atrophy (Figure 3. 
Endometrial cycle) (Nair and Taylor, 2010). Due to progesterone withdrawal, the 
constriction of spiral arterioles takes place and results in decreased blood flow, 
causing tissue ischemia. Prostaglandin release in endometrium causes contr-
actions of uterine muscles which helps to get rid of degraded tissue. 
The description above shows the menstrual cycle from usual and frequently 
repeating side – when the oocyte is not fertilized, and the cycle ends with 
menstrual bleeding. But there is another side, which ends with pregnancy and is 
discussed below.   
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Figure 3. Average menstrual cycle. LH – luteinizing hormone (light blue); FSH – 
follicle-stimulating hormone (red); hCG – gonadotropin (orange); WOI – window of 
implantation; LH+2/+8 – indicates days after LH peak, where LH+2 indicates early-
secretory (ESE) and LH+8 mid-secretory endometrium (MSE). “Gonadotropins” panel 
shows fluctuations of LH and FSH during the menstrual cycle, where LH peak occurs 
prior to ovulation. “Steroid hormones” panel shows changes in estradiol and pro-
gesterone. The “ovarian cycle” panel shows follicle maturation, oocyte release, and 
luteinization. “Endometrial cycle” panel shows endometrial growth, proliferation (Proli-
ferative), vascularisation (Secretory) and shedding (Menses). Adapted from William 
Obstetrics 25e (Cunningham et al., 2018).  
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1.4. Receptive endometrium and embryo implantation 
A properly functional mature endometrium is necessary for successful embryo 
implantation. The tissue itself can be divided into two layers – basal and func-
tional layer (Figure 2) (Gómez et al., 2015). The basal layer is a source for the 
functional layer, consisting mainly of progenitor cells. The functional layer 
contains glands and stroma, grows from the basal layer and is shed every cycle 
(Figure 2). Endometrial tissue is composed of diverse cell types, mainly stromal 
and epithelial (glandular and luminal) cells, but also endothelial cells, leuko-
cytes, other immune cells, and progenitor stem cells (Figueira et al., 2011).  
The endometrium is receptive to the embryo during a short period of time 
called the window of implantation (WOI), which lasts about 48 hours (Gómez 
et al., 2015). WOI takes place in the mid-secretory phase at days ~7–10 after the 
LH peak of the 28-day menstrual cycle (Figure 3 Endometrial cycle) (Kao et al., 
2002; Riesewijk, 2003). For the endometrium to reach its receptive state, the 
tissue undergoes vast structural changes each cycle, such as vascularization; a 
shift in proportions between stromal and epithelial cells, where epithelial cells 
become more dominant; decidualization of stromal cells; and functional and 
structural changes of epithelial cells. The embryos that implant during this time, 
show 84% chance for continuing pregnancy, whereas embryos implanted on day 
11 after LH peak show only 18% chance (Kao et al., 2002; Wilcox et al., 1999). 
The embryo implantation process takes place in three stages: apposition, 
adhesion, and invasion (Achache and Revel, 2006; Egashira and Hirota, 2013; 
Kao et al., 2002). During the apposition stage, the embryo changes its polarity 
and the zona pellucida (embryonal coating) is shed. Adhesion and invasion 
steps are quite self-explanatory: during adhesion, the embryo adheres to the 
endometrium, and during invasion invades into the maternal tissue. Embryo 
implantation involves a complex sequence of signaling events, such as inter-
actions between cells, and between cells and the extracellular matrix. These 
events are mediated by lectins, integrins, interleukins (IL), matrix-degrading 
enzymes, growth factors (GF), cytokines, enzyme inhibitors and others (Figure 
4) (Achache and Revel, 2006; Di Pietro et al., 2013; Kao et al., 2002; Paul et al., 
2018; Singh et al., 2011). The maternal immune response is also regulated 
during the implantation step, to prevent severe immunological response to 
embryo (Gómez et al., 2015; Palomino et al., 2018), but at the same time protect 
the mother from potential pathogens. The embryo-maternal communication is 
based on interactions between ligands and their receptors, for example, leu-
kemia inhibitory factor (LIF) and LIF-receptor (LIFR) play a role as commu-
nication signals between uterine and embryonic cells, thus being crucial for 
successful implantation (Cavagna and Mantese, 2003; Paul et al., 2018). The 
non-coding RNAs also have an important role in embryo-maternal communi-
cation. One of these non-coding RNAs are miRNAs, that are secreted by both 
embryo and endometrium, and are involved in embryo-maternal communication 
during the implantation step (Paul et al., 2019; Vilella et al., 2015). To protect 
signaling molecules from degradation in extracellular space, they are packed 
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into extracellular vesicles (EV). EVs are eukaryotic cell-derived vesicles of 
different sizes that carry signaling molecules like miRNAs and other non-
coding RNAs, mRNAs, and proteins. They are found in various biofluids and 
they mediate intercellular communication between cells and tissues (Giacomini 
et al., 2017; Homer et al., 2017; Machtinger et al., 2015). Elisa Giacomini and 
coauthors have shown that endometrial stromal and epithelial cells uptake 
blastocyst EVs derived from IVF embryo spent media of 5-day old embryos, 
and that vesicles absorbed by trophoblasts enhance trophoblast adhesive capa-
city, providing evidence of an intracellular mechanism of embryo-maternal 
communication in humans (Giacomini et al., 2017). Additionally, there is some 
evidence that endometrial microbiota also influences the success of embryo 
implantation and placental bacterial community could play some role in com-
munication between mother and embryo (Kyono et al., 2018; Moreno et al., 
2016).  
 
Figure 4. Visualization of some factors involved in implantation. IL11 and Activin A 
promotes endometrial decidualization. HB-EGF promotes endometrial cellular proli-
feration, decidualization, and glandular secretion. Estrogen and progesterone regulate 
IGF1 production in the endometrium, regulate IL6 secretion and facilitate blastocyst 
attachment. TGFβ in endometrium promotes proliferation, decidualization, implanta-
tion, and remodulation of the endometrium. In the case of an embryo, TGFβ increases 
invasiveness, promotes trophoblast adhesion and pre-/post-implantation development of 
the embryo. COX-2 regulates prostaglandins, that increase vascular permeability and 
adhesiveness of endometrium, and promotes embryo implantation. Based on Singh et 
al. (Singh et al., 2011). 
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In conclusion, successful embryo implantation depends on various factors like 
blastocyst quality, endometrial receptivity state, synchronization of embryo 
developmental stages, and successful communication between maternal and 
embryonal cells (Kao et al., 2002; Singh et al., 2011). 
 
 
1.5. Transcriptomics methods 
It is shown that inadequate uterine receptivity is the reason for two-thirds 
implantation failures in IVF cycles, and one third is due to embryo factors (Hu 
et al., 2014). Knowing receptivity markers would help to improve IVF success 
rates, and one way of doing this is to study transcriptomic changes during the 
transition from early-secretory (ESE) to mid-secretory endometrium (MSE) in 
healthy fertile women. 
The first attempts to study the whole transcriptome were undertaken in the 
early 1990s, and by the end of the decade, transcriptomics became a widespread 
discipline (Hrdlickova et al., 2017; Lowe et al., 2017). The most popular 
methods to study the transcriptome are microarrays and RNA sequencing 
(RNA-seq), but which were preceded by expressed sequence tag (EST) and 
serial/cap analysis of gene expression (SAGE/CAGE). Both microarray and 
RNA-seq are based on the methods used for DNA analysis, thus before 
transcriptome analysis, the RNA is reversely transcribed to complementary 
DNA (cDNA) (Figure 5) (Hrdlickova et al., 2017; Lowe et al., 2017). 
The samples usually used for transcriptome studies are tissue biopsies or 
“bulk” tissue, blood, cultured cells or single cells. Biopsies are used because 
each tissue has its own characteristic expression signature. While blood is the 
easiest tissue to get, it usually lacks transcripts originating from tissues/cells 
other than blood cells, so it is better to get a biopsy from the tissue of interest 
rather than use blood. The cultured cells or single cells are mainly used to 
observe cell-specific expression patterns, especially in the case of complex 
tissues such as cancers or endometrium (Kanter and Kalisky, 2015). Endo-
metrial receptivity expression studies have been conducted using mainly micro-
arrays (Altmae et al., 2010; Borthwick et al., 2003; Díaz-Gimeno et al., 2014; 
Kao et al., 2002; Mirkin et al., 2005; Riesewijk, 2003), but recently some 
studies have used RNA-seq (Hu et al., 2014; Marí-Alexandre et al., 2016) or 
single-cell RNA-seq (Lucas et al., 2018). 
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Figure 5. Comparison between RNA microarray and RNAseq technologies. In 
eukaryotes, genes are transcribed and spliced to produce mature mRNA (red). In in vitro 
analysis, the RNA is extracted, and in the case of microarrays, reverse transcribed to 
cDNA (blue) and then fragmented to double-stranded cDNA (ds-cDNA) fragments, 
while for RNA-seq, the extracted RNA is fragmented and then fragments are reverse 
transcribed, resulting in ds-cDNA fragments. During the following step, array ds-cDNA 
fragments are labeled with fluorescent tags (orange, dark blue, green, pink) and labeled 
fragments bind to the ordered array of complementary oligonucleotides, while RNA-seq 
ds-cDNA fragments are sequenced with high-throughput, short-read sequencing 
methods. In the last step – in silico analysis, arrays fluorescence intensities are 
measured, showing an abundance of sequences that represent genes of interest, or RNA-
seq sequences are aligned to a reference genome or de novo assembled to reconstruct 
transcribed genome regions. Later this data could be used for gene annotation, 
expression level measurements, and detection of splice variants. Adapted from Lowe et 
al. (Lowe et al., 2017). 
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1.5.1. Expression microarrays vs RNA sequencing 
Many studies compared RNA-seq with expression arrays and found that the ad-
vantages of microarrays are low price and easier data analysis. On the other hand, 
RNA-seq is more precise and sensitive to fluctuations of low gene expression. It 
has also a broader range of detectable transcripts and their isoforms due to saving 
strandedness and is capable of identifying single nucleotide variations (SNV) and 
genetic polymorphisms. In comparison to microarrays, RNA-seq needs less RNA 
material (RNA-seq ~1 ng, array ~1 μg ), could be used without a reference 
genome and assembled de novo, thus it is a good tool for measuring genome-wide 
expression even in organisms without any reference data (Hrdlickova et al., 2017; 
Lowe et al., 2017; Marioni et al., 2008; Zhao et al., 2014). Microarrays require 
special reference transcripts for probes, and so are not suitable for poorly studied 
organisms and detecting novel transcripts (Lowe et al., 2017). One advantage of 
RNA-seq is the DNA sequencing base, hence the progress of genome sequencing 
technologies also results in the progress of RNA-seq methods. 
In spite of all advantages, RNA-seq has also some shortcomings like high 
variability between technical replicates with low coverage (McIntyre et al., 
2011). In contrast to microarray studies, where probe annotations are provided 
by the manufacturer, data processing and analysis protocols are well established, 
and the results are limited to already known transcripts, RNA-seq needs properly 
chosen analysis methods, depending on analyzed species, data quality, availability 
of samples, and scientific question (Schurch et al., 2016; Seo et al., 2016; 
SEQC/MAQC-III Consortium, 2014). For example, for differential analysis 
edgeR (McCarthy et al., 2012; Robinson et al., 2010) and DESeq2 (Love et al., 
2014) are recommended, in case there are <12 replicates available, and DESeq 
(Anders and Huber, 2010) if more than 12 (Schurch et al., 2016).  
It has been shown that current microarrays, like Affymetrix HTA 2.0, are as 
good as RNA-seq in detecting protein-coding RNAs and some non-coding 
RNAs, and in some cases, where there is a need to find the slightest changes in 
gene expression especially for low abundant transcripts, could even outperform 
RNA-seq, thus it is advised to use microarrays for differential expression 
analysis of known genes, while RNA-seq for thorough analyses with detection 
of unknown genes, and both platforms together in the case of alternative 
splicing analysis (Nazarov et al., 2017). 
 
 
1.5.2. RNA-seq data processing and analysis 
Before downstream analysis, such as differential expression analysis can take 
place, the raw RNA-seq reads should be prepared properly. The preparation steps 
usually include quality check; adapter trimming; removal of low-quality reads, 
where the low quality corresponds to base call accuracy; alignment to known 
reference or de novo assembly if necessary; quantification on the gene, exon or 
transcript level; and in the end differential expression analysis, if the aim was to 
find expression differences between conditions (Figure 6) (Lowe et al., 2017). 
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Figure 6. Preprocessing, -mapping and -analysis scheme for RNA-seq data. Data is 
colored in pink, preprocessing steps are green, alignment/assembly steps – orange, 
quantification steps – blue, tools – yellow, and differential expression analysis is purple. 
First, the raw reads are quality checked, next if necessary are trimmed and quality 
filtered. Then aligned to the reference genome or assembled de novo. The reads may be 
quantified with or without alignment/assembly step. After quantification, the expression 
of transcripts is analyzed, providing differentially expressed transcripts as a result. 
 
 
First of all, a quality check of raw reads is needed to get an overview of read 
base quality, adapter sequence presence, the amount and origin of overrepre-
sented sequences (Lowe et al., 2017), and one of the most popular tools for this 
step is the FastQC software (Andrews, 2010). This step helps to correct data for 
further steps before alignment, as low-quality data influences alignment quality, 
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and thus may lead to poor analysis results. The trimming step is necessary to 
remove adapters or low-quality bases from the beginning and end of the read, 
thus eliminating incorrect alignment. During the trimming step, it is also pos-
sible to remove overrepresented sequences, depending on the trimming tool. For 
example, Trimmomatic (Bolger et al., 2014) also includes a low-quality read 
removal option. The removal of low-quality reads improves further alignment – 
it lowers the amount of multi-mapped or wrongly mapped reads. One of the 
tools that could be used for this step is the FASTQ quality filter tool from the 
FASTX-Toolkit (Hannon lab, 2009).  
When the data is filtered and trimmed, it is ready for the next step – align-
ment to a suitable reference or for de novo assembly (Lowe et al., 2017). Many 
tools are available for alignment, the most popular of them are TopHat2 (Kim et 
al., 2013) or STAR (Dobin et al., 2013), and for de novo assembly, Trinity 
(Grabherr et al., 2011) or Velvet-Oases (Schulz et al., 2012). The alignment step 
can be skipped using alignment-free quantification tools like Kallisto (Bray et 
al., 2016) and Salmon (Patro et al., 2017). 
Alignment is followed by quantification of expression on the gene, exon, or 
transcript levels (Lowe et al., 2017). One broadly used tool to quantify expres-
sion on gene or exon levels is the HTSeq-count script from the HTSeq package 
(Anders et al., 2015). This script provides counts that can be further used in 
differential expression analysis. Another tool – Cufflinks – provides FPKMs 
(fragments per kilobase of transcript per million fragments mapped) (Trapnell et 
al., 2010, 2012), in which case the transcript length is taken into account, in 
contrary to count data that does not account for transcript length. The RSEM (Li 
and Dewey, 2011) package is the best for de novo assembled genomes, as it 
quantifies transcript abundances and does not rely on reference genomes. 
RNA-seq data can be used for a wide variety of analyses, most commonly 
for differential expression analysis between some study groups; allele specific-
expression analysis; or splicing site analysis (Lowe et al., 2017). Most popular 
tools for the differential expression analysis are: for the FPKM based analysis – 
Cuffdiff, a tool from Cufflinks package (Trapnell et al., 2010, 2012); for the 
count data, several R packages mentioned above, like edgeR, DESeq/DESeq2, 
DEGSeq (Wang et al., 2010), limma/voom (Costa-Silva et al., 2017; Law et al., 
2018; Lowe et al., 2017) are available. Data normalization is carried out before 
analysis, usually, some normalization methods are included in the package. The 
normalization is necessary for accounting for factors that could influence 
mapped read numbers, such as gene length, GC-content, sequencing depth, thus 
increasing variability between and within samples (Evans et al., 2018). The 
differential analysis may be carried out using various statistical models de-
pending on the package (Costa-Silva et al., 2017), for example, generalized 
linear models are used by edgeR (McCarthy et al., 2012), DESeq/DESeq2 
(Anders and Huber, 2010; Love et al., 2014), baySeq (Hardcastle and Kelly, 
2010), and limma (Ritchie et al., 2015). After obtaining a list of differentially 
expressed genes (DEGs), at least some of them should be validated with another 
method, like qPCR (Costa-Silva et al., 2017; Lowe et al., 2017). 
28 
1.5.3. Factors affecting RNA-seq analysis 
When planning an optimal study design, it must be kept in mind that RNA-seq 
analysis results can be affected by biological factors stemming from study sample 
donor’s phenotype, life-style and environment; or technical factors from sample 
collection, storage and preparation phases; or data preprocessing and analysis 
methods. In the early steps of sample collection and RNA preparation, the time 
between blood/biopsy collection and RNA isolation, or RNA isolation protocols, 
reagents used and their quality, laboratory and personnel habits and experience – 
all of them are a possible source of batch effects, that may lead to technical 
variability resulting in gene expression differences bigger than the differences 
between measurable conditions (Leek et al., 2010; Schurmann et al., 2012; 
Williams et al., 2014). In the next steps, the nucleic acid amplification, platforms 
used for that, sample preparation conducted on separate date and time, library, and 
even sequencing lane affect further analysis outcome through different batch 
effects (Leek et al., 2010; Schurmann et al., 2012; Williams et al., 2014). Thus, it 
is important to eliminate, minimize or at least take into account technical effects 
on early analysis steps, for example, by indexing and multiplexing samples to 
minimize line effects (Williams et al., 2014), using the same protocols and 
reagents for sample preparation, and/or reducing the time between tissue 
collection and RNA isolation to minimize possible RNA degradation. Recording 
changes in sample preparation could help to take these differences into account 
during the analysis step (Leek et al., 2010; Schurmann et al., 2012). The extracted 
total RNA on average has 90% of ribosomal RNA (rRNA) and only 2% of 
mRNA, so there is a need for mRNA enrichment using polyA selection, or rRNA 
level reduction using rRNA depletion methods (Hrdlickova et al., 2017; Nazarov 
et al., 2017; Sheng et al., 2016). While the polyA selection leads to 3’ bias in the 
distribution of reads, the depletion may lead to unpredictable changes at exon-
level (Nazarov et al., 2017). These biases could be reduced during counting or 
normalization steps by using appropriate statistical models (Tuerk et al., 2017). 
After sequencing comes the data preprocessing step that includes quality 
control and other preparation steps before mapping. It is necessary to check the 
GC-content, overrepresented sequences, adapter content, and base quality, be-
cause all these parameters could affect the downstream sequence alignment 
(Lowe et al., 2017; Sheng et al., 2016; Williams et al., 2014). Data can be 
improved before sequence alignment by trimming out the adapters, removing 
bad quality bases in the read start/end, or filtering out overall bad quality reads 
(Lowe et al., 2017; Sheng et al., 2016). The alignment step could affect analysis 
due to falsely aligned reads or multi-mapped reads. It is important to use 
options suitable for dataset and analysis of interest, and check the quality of 
aligned data (Sheng et al., 2016; Williams et al., 2014). Quality check gives a 
good overview of the numbers of unmapped and mapped reads, insert size, 
multi-mapped reads and it helps to detect 3’ or 5’ bias, GC bias, and batch 
effects (Sheng et al., 2016). During the counting step, only uniquely mapped 
reads should be counted. The choice of counting tool is made depending on the 
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aims and analysis type, because in some cases transcript length may affect ana-
lysis results (Lowe et al., 2017; Nazarov et al., 2017; Sheng et al., 2016; Wil-
liams et al., 2014). The read count approach is usually used for differential 
expression analysis on gene or exon level.  
The analysis results in the case of ‘bulk’ tissue could be influenced by cellu-
lar composition, which varies from sample to sample (Gong et al., 2011; Schel-
ker et al., 2017; Shen-Orr and Gaujoux, 2013). Several approaches have been 
developed to address this issue, either using physical cell sorting methods (such 
as flow cytometry) to obtain pure cell fractions for transcriptomic analysis, or 
computational deconvolution, which uses various statistical approaches to 
calculate estimated cellular fractions. 
Physical cell sorting is more complicated and needs special instruments, but is 
more accurate in comparison to computational deconvolution. There are several 
techniques available to obtain enriched cellular populations: fluorescence-acti-
vated cell sorting (FACS), magnetic-activated cell sorting (MACS), laser capture 
microdissection (LCM), manual cell picking and microfluidic isolation (Figure 7) 
(Hu et al., 2016). FACS (Figure 7 A) is the most sophisticated and user-friendly 
technique, that allows simultaneous quantitative and qualitative single-cell ana-
lysis based on cell size, granularity and fluorescence antibody tagging of cell-
specific antigens. The fluorescent probe labeled cells are exposed to laser while 
running through cytometry, so fluorescence detectors could distinguish between 
cell types based on user predefined characteristics. The droplets with cells of 
interest are then charged and the electrostatic system directs identically charged 
droplets into appropriate collection tubes (Hu et al., 2016). MACS (Figure 7 B) is 
another commonly used technique, where cells are labeled with magnetic beads 
wearing antibodies. The external magnetic field recognizes MACS bead con-
jugated antibodies, and thus polarize labeled cells while unlabeled cells are 
washed out (Hu et al., 2016). LCM (Figure 7 C) is based on microscopic 
visualization and the system consists of an inverted microscope, controlled 
microscope stage with vacuum capability, a solid-state near laser diode, laser 
controller, CCD (Charge Coupled Device) camera and monitor. The cells of 
interest are visualized with a microscope and then the transparent thermoplastic 
film on the cap above the cells is melted by laser impulse and fused with the 
targeted cells. The film with targeted cells is then removed, thus separating them 
from the “bulk” tissue (Hu et al., 2016). Manual cell picking (Figure 7 D) is also 
based on microscopic visualization, but instead of laser with melting film, the 
microscope is equipped with micro-pipettes, which allows isolating live cells (Hu 
et al., 2016). Alternatively, manual cell-picking can also be performed without 
micro-manipulation. Microfluidic chip (Figure 7 E) is based on fluid physico-
chemical properties, that change in micro-channels. The chip channels are 
modified so they can bind targeted cells, while other cells are washed out with 
buffer (Hu et al., 2016). 
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Figure 7. Schematic of five cell sorting methods. A. FACS. Labeled cells are exposed 
to laser as a stream of single-cell droplets. Then the fluorescence detector charges cells 
according to their fluorescence and light scatter characteristics. The electronic 
deflection system further guides the charged cells according to their charge into the 
collecting tubes. B. MACS. The fusion of antibody with magnetic beads is used to label 
cells of interest. Labeled cells are separated from the cell mixture with a magnetic field 
(S and N magnets) and collected to the tube. C. LCM. The cap with the thermoplastic 
film is moved above the cells. Then the infrared (IR) laser impulse is sent through the 
cap over cells of interest melting the film. The cells of interest adhere to the film and are 
removed with the cap from the cell mixture. D. Manual picking. Cells of interest are 
collected with a micromanipulator connected glass pipette under a microscope and 
transferred to the tube. E. Approximate microfluidic chip separation. In general: using a 
system of capillaries and buffer fluid, the cells are separated from cell mixture and 
collected to the collecting tubes. Based on Hu et al. (Hu et al., 2016). 
 
 
There are several methods to computationally estimate cell fractions in the 
whole tissue, most of which are developed for whole blood samples (Abbas et 
al., 2009; Gong and Szustakowski, 2013; Liu et al., 2008a; Newman et al., 
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2015; Qiao et al., 2012; Shen-Orr and Gaujoux, 2013). These statistical methods 
need only expression datasets (RNA-seq or microarray) and sometimes cell-
specific RNA expression profiles, but in comparison to physical methods 
provide estimated cell fractions or arbitrary units (Gong and Szustakowski, 
2013; Newman et al., 2015; Qiao et al., 2012; Schelker et al., 2017; Sturm et al., 
2018). There are reference-free and reference-based methods, where first ones 
require a cell-type-specific signature and ‘bulk’ tissue expression data, while 
second ones need only ‘bulk’ tissue expression data (Avila Cobos et al., 2018; 
Teschendorff and Zheng, 2017). The cell-type-specific expression set usually 
includes cell-type-specific whole-genome expression patterns or some cell-type-
specific signature genes (Qiao et al., 2012; Sturm et al., 2018; Teschendorff and 
Zheng, 2017). 
In the case of the DeconRNASeq, the “bulk” tissue dataset should be limited 
only to transcripts that are present in cell-specific dataset (Gong and Szusta-
kowski, 2013). Also, DeconRNASeq uses normalized transcriptional measure-
ments from pure cell types and heterogeneous tissues, where measurements 
could be made on the gene, transcript or exon level, that are all provided by the 
user, so there are no limitations to cell and/or tissue types (Gong and Szusta-
kowski, 2013). At the same time, CYBERSORT has its own set of reference 
genes for 22 hematopoietic cells and the user should provide only expression 
profiles for whole blood samples (Newman et al., 2015). The limitation of 
reference-based methods is reference availability and quality. For example, the 
overlap of signature genes between cell types could lead to spillover effect, 
where a high abundance of one cell type could lead to predicting higher abun-
dance for another cell type (Sturm et al., 2018). The quality of the signature set 
also affects distinguishing between cell subpopulations (Qiao et al., 2012; Sturm 
et al., 2018). Another limitation is not taking into account cell-cell interactions, 
that could alter gene expression profiles (Teschendorff and Zheng, 2017). 
The reference-free methods, such as surrogate variable analysis (SVA) or in-
dependent SVA (ISVA) that adjust the data to any type of confounder (Teschen-
dorff and Zheng, 2017), deconvolute the expression data without prior know-
ledge about cell-types and can account for cell-cell interactions (Avila Cobos et 
al., 2018; Teschendorff and Zheng, 2017). Wang and colleagues provide a new 
deconvolution method implemented into CAM (convex analysis of mixtures) 
package that makes unsupervised deconvolution without using any cell type 
reference sets and needs only normalized gene expression values with a priori 
removed batch effects (Wang et al., 2016). The method is based on a theorem, 
where the scatter simplex (linear subspace) of mixed (bulk tissue) expressions is 
the compressed and rotated scatter simplex of pure (cell-type-specific) expres-
sions. The expression of a separate gene in a cell-type is modeled as being 
linearly proportional to the abundance of that cell-type. CAM geometrically 
identifies vertices (corners) of mixed gene expression scatter simplex, where 
each vertex corresponds to cell-type-specific expression and contains cell-type 
signature genes. The method works accurately only if the number of hetero-
geneous samples is equal to or greater than the number of cell types in these 
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samples (Wang et al., 2016). LinSeed is another package for unsupervised 
deconvolution using a similar approach (Zaitsev et al., 2019). 
The estimated cellular fractions obtained from deconvolution analysis can be 
used in the downstream differential expression analysis. In the bulk-tissue 
samples, tissue-averaged expression levels are measured, thus expression contri-
bution of less abundant cell-types could be masked by that of more abundant cell-
types (Avila Cobos et al., 2018); therefore, the adjustment according to cellular 
composition helps to prevent loss of signal from less abundant cell types, thus 
improving the quality of the analysis. 
 
 
1.6. Role of gene expression in endometrial  
receptivity context 
Studies into the transcriptomic changes taking place around the WOI have pro-
vided valuable insights into the underlying reproductive biology. These studies 
have analyzed the differences in expression between early-secretory (ES) and 
mid-secretory (MS) phases, and have usually used samples from women aged 
between 20–40 years as in this age interval menstrual cycle of healthy women is 
stable and women are most fertile (Hu et al., 2014; Kao et al., 2002; Koot et al., 
2016; Liu et al., 2008b; Riesewijk, 2003; Ruiz-Alonso et al., 2013; Sherman 
and Korenman, 1975; Zhang et al., 2012a). The participants should have normal 
BMI, as bodyweight can influence fertility (Koot et al., 2016; Ruiz-Alonso et 
al., 2013). They are not allowed to take hormonal contraceptives for at least 3 
months before the study, because the expression of many genes is influenced by 
hormonal levels (Hu et al., 2014; Koot et al., 2016; Liu et al., 2008b; Zhang et 
al., 2012a). Usually, participating women have at least one live-born child that 
indicates their fertility (Altmae et al., 2010). Ovulation tests are used to track 
the LH peak and histological dating according to Noyes’s criteria (Noyes et al., 
1950, 1975) is used to evaluate endometrial phase (Altmae et al., 2010; Kao et 
al., 2002; Riesewijk et al., 2003; Zhang et al., 2012a). The smoking status is 
also taken into account (Koot et al., 2016; Riesewijk et al., 2003). 
 
 
1.6.1. Endometrial receptivity microarray studies 
Before the gene expression array era, the studies of transcription mainly con-
centrated on one or several genes. The invention of microarrays in 1990 and 
their wide-spread use made it possible to study the transcription of many genes 
at once (Marioni et al., 2008; Zhao et al., 2014). The first endometrial micro-
array studies were published in 2002, when Carson et al. and Kao et al. used ca 
12k gene micro-arrays to find differences between ESE and MSE (Carson et al., 
2002; Kao et al., 2002). They found DEGs associated with the extracellular 
matrix, signaling pathways, transcription factors (Carson et al., 2002; Kao et al., 
2002), growth factors/cytokines (Carson et al., 2002), immune modulators (Kao 
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et al., 2002) and others. Their works were the first to show the complexity of the 
transition process between ESE to MSE. Some further studies tried to link gene 
expression differences with progesterone and estrogen level fluctuations by 
searching progesterone and estrogen receptor DNA binding sites in DEGs 
(Borthwick et al., 2003; Mirkin et al., 2005). These studies used a small number 
of samples, each time-point was collected from different women, and they did 
not take into account the effects of BMI, and smoking status (Borthwick et al., 
2003; Carson et al., 2002; Kao et al., 2002). A more advanced sample collecting 
approach was used by the Riesewijk group – biopsies for ESE and MSE were 
collected from the 5 women within the same menstrual cycle, which helped to 
eliminate interindividual variability. Their DEGs showed some overlap with 
previous studies, where up-regulated DEGs were more overlapping with Kao et 
al. work and down-regulated DEGs showed bigger overlap with Carson et al. 
study (Carson et al., 2002; Kao et al., 2002; Riesewijk et al., 2003). The overlap 
between three studies was low due to differences in samples/sample collecting, 
microarrays used, analysis techniques used and are pointed out in further works 
(Riesewijk et al., 2003; Zhang et al., 2012). Further studies used a bigger 
number of samples (Mirkin et al., 2005), used animal models (Vallejo et al., 
2010), looked into differences because of IVF (Liu et al., 2008b) or between 
fertile women and infertile patients (Altmae et al., 2010), found some overlap 
with the previous studies (Altmae et al., 2010; Liu et al., 2008b; Mirkin et al., 
2005; Vallejo et al., 2010) and added new pieces of information into the endo-
metrial regulation puzzle at the gene expression level. Still, the overlap between 
array studies remained low (Gómez et al., 2015; Zhang et al., 2012). 
 
 
1.6.2. The era of ERA (Endometrial Receptivity Array) 
Endometrial receptivity transcriptome studies have also had a practical output, 
as in 2010, Diaz-Gimeno and co-workers created a new tool for predicting 
endometrial receptivity and the WOI. The tool consisted of an array of 238 
selected genes expressed at three stages of the endometrial cycle and a bio-
informatic predictor. The bioinformatic predictor was based on a support vector 
machine algorithm and was trained for two conditions: endometrial receptivity 
(ES, MS, proliferative) and pathological classifications (implantation failure, 
hydrosalpinx) (Díaz-Gimeno et al., 2011). They also compared the test with 
classical histological dating according to Noyes criteria (Noyes et al., 1950, 
1975). The ERA test made better predictions than histologists in most cases and 
was reproducible in time (Díaz-Gimeno et al., 2013). The ERA test was tested 
on recurrent implantation failure (RIF) patients, as the implantation failure may 
be caused by WOI misplacing. The implantation and pregnancy rates were 
higher after ERA test implementation, thus helping to plan embryo transfer 
according to personalized WOI timing (Ruiz-Alonso et al., 2013). However, 
RIF is still too complex to solve only with ERA testing and embryo quality 
check (Koot et al., 2016). In 2017, Encisco and colleagues came out with 
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another WOI timing test, that is based on RT-qPCR, and is named as ER 
Map®/ER Grade®. The test includes 40 genes that were selected from the 
literature based on the highest fold change between non-receptive and receptive 
phases, and additionally the genes that explained almost 100% of the sample 
variance according to PCA (principal component analysis) results. The overlap 
with the ERA gene set is relatively small, only ANXA4, AQP3, ARG2, GPX3, 
MAOA, MT1H, and SCGB2A2 genes are present in both tests, but despite such 
small overlap, ER Map®/ER Grade® classification matched with ERA results 
in 97.59% of the training set and 91.67% of the testing set samples (Enciso et 
al., 2018).  
 
 
1.6.3. Endometrial receptivity RNA-seq studies 
Only some endometrial studies have used RNA sequencing, possibly because 
the method is more expensive and requires more complicated data preparation 
and analysis in comparison with array-based studies. The first differential 
expression study between ESE and MSE using the RNA-seq technique was 
made by Hu and colleagues (Hu et al., 2014). They used samples from 12 
women, 6 per both ES and MS phase (6 of them – 3 samples per phase – were 
used for the main analysis, and the other 6 as validation set). They found 1,099 
up-regulated and 1,237 down-regulated genes, which correlated with results 
from the validation set (2,212 genes overlapped; Pearson correlation between 
fold changes: R=0.9994). There was also gene overlap with previous array 
studies: with Zhang et al. (Zhang et al., 2016) 144 of the 148 genes (97%) and 
with Tapia et al. (Tapia et al., 2007) 55 of the 61 genes (90%) (Hu et al., 2014). 
The second study using RNA-seq for detecting transcription during the 
transition between ESE to MSE was more focused on noncoding RNAs. They 
found 3,297 significantly differentially expressed mRNAs, of which 1,408 
overlapped with the previous study (Hu et al., 2014), showing that despite 
differences in sample sizing and methodology, there is bigger concordance 
between RNA-seq studies than array studies (Sigurgeirsson et al., 2016). The 
gene expression studies mentioned above have their limitations, most impor-
tantly small sample sizes. Rahmioglu et al. showed that at least 500 samples are 
needed for detection of 1.5 FC (fold change) gene expression in ca 80% of 
transcripts (Rahmioglu et al., 2017), therefore endometrial RNA-seq studies 
conducted thus far have been underpowered.  
Most of the studies have used endometrial whole-tissue biopsies, where cell 
proportions vary, as the endometrium is a complex tissue with remarkable 
structural changes happening in different phases of the menstrual cycle, and also 
the biopsy size and intrauterine location vary. Cell composition should be taken 
into consideration during analysis, to avoid bias towards the expression pattern 
of cells with a larger proportion. The participating women’s lifestyle, such as 
smoking, or some medical treatments as hormonal therapy, or women’s age 
could drastically influence the results, so should also be taken into account. 
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Thus, there is still a need for more studies using larger sample sets and proper 
methodology to find more robust support for previous findings.  
 
 
1.6.4. Non-coding RNAs 
There are a lot of other non-coding RNA molecules transcribed from the genome 
together with coding RNAs, that play an important role in genome regulation 
(Chen et al., 2017a; Hüttenhofer et al., 2005; Moazed, 2009; Montazerian et al., 
2018; Tesfaye et al., 2018; Trzybulska et al., 2018). Non-coding RNAs are 
grouped into small non-coding RNAs, like short interfering RNAs (siRNA); 
miRNAs; PIWI-interacting RNAs (piRNAs); and into long non-coding RNAs 
(lncRNAs), like long intergenic noncoding RNAs (lincRNAs) and transcribed 
ultraconserved regions (T-UCRs) (Hüttenhofer et al., 2005; Moazed, 2009; 
Trzybulska et al., 2018). For example, lncRNAs may regulate allele-specific 
expression, such as X chromosome inactivation and imprinting; may act as re-
cruiter factors; regulate other lncRNAs (Cedar and Bergman, 2009; Hüttenhofer 
et al., 2005; Kung et al., 2013; Trzybulska et al., 2018); interfere with miRNA-
mediated mRNA destabilization by masking miRNA binding-sites or acting as 
miRNA “sponges” (Kung et al., 2013). It has been shown that lncRNAs can 
also contribute to endometrial cancer development (Chen et al., 2017a; Sigur-
geirsson et al., 2016). The small RNAs also may act at the DNA and chromatin 
level (Hüttenhofer et al., 2005; Moazed, 2009).  
MiRNAs, small RNAs that recently drew interest in the reproductive con-
text, are 18–24 bp short protein non-coding molecules, that can regulate intra-
cellular gene expression locally in parent cells or may influence it distantly via 
transfer by blood flow, making them good disease biomarker candidates (Hull 
and Nisenblat, 2013; Montazerian et al., 2018; Paul et al., 2018; Tesfaye et al., 
2018; Trzybulska et al., 2018). miRNAs are synthesized in three steps: first, 
primary miRNA is transcribed from the genome; second, it is cleaved to pre-
miRNA; and third, it is transported into the cytoplasm, where it becomes a 
mature miRNA (Figure 8) (Hull and Nisenblat, 2013; Montazerian et al., 2018; 
Paul et al., 2018; Tesfaye et al., 2018). To regulate gene expression, the mature 
miRNA binds to the Argonaut proteins in the RNA-induced silencing complex 
(Hull and Nisenblat, 2013; Hüttenhofer et al., 2005; Moazed, 2009; Paul et al., 
2018; Tesfaye et al., 2018; Trzybulska et al., 2018). One miRNA could regulate 
hundreds of transcripts, while one transcript could be regulated by several 
miRNAs (Altmäe et al., 2013; Hull and Nisenblat, 2013; Seitz, 2009). These 
small molecules mainly down-regulate the expression of mRNAs by cleavage 
and deadenylation or up-regulate by targeting gene promoters (Montazerian et 
al., 2018; Paul et al., 2018). The miRNAs are circulating in blood flow as part 
of microvesicles or lipoprotein complex compound, thus they are protected 
from degradation by RNases (Hull and Nisenblat, 2013; Montazerian et al., 
2018; Trzybulska et al., 2018).  
 
36 
 
Figure 8. Overview of miRNA synthesis: pri-miRNA is transcribed in the nucleus from 
the gene, then cleaved to pre-miRNA by Drosha enzyme and transported to the 
cytoplasm where it is cleaved by Dicer to mature miRNA. The mature miRNA may 
bind Argonaut and thus form the RISC complex. This complex can terminate protein 
translation by binding to the open reading frame or lead to mRNA degradation when 
binding with 3’UTR.  
 
 
The expression of endometrial miRNAs is cell-specific, thus it probably media-
tes cross-talk between endometrial cell-types (Hull and Nisenblat, 2013; Monta-
zerian et al., 2018). Altmäe and colleagues found miRNAs, differentially 
expressed in endometrial transition from ES to MS phase, that regulate genes 
involved in epithelial and endothelial cell differentiation, implantation, cell 
communication and migration, and inflammatory responses (Altmäe et al., 
2013). Up-regulation of miRNAs in epithelial cells in the MS phase was also 
demonstrated by others (Kuokkanen et al., 2010; Paul et al., 2018), where some 
of them are, probably, down-regulating expression of cell-cycle specific genes, 
thereby suppressing cell proliferation (Kuokkanen et al., 2010). miRNA poten-
tial role in creating immune-tolerant environment during the secretory phase 
and regulation of endometrial decidualization (Paul et al., 2018; Sigurgeirsson 
et al., 2016), involvement during embryo implantation process and connection 
with recurrent miscarriage (Feng et al., 2018) and endometriosis has also been 
shown (Hull and Nisenblat, 2013). Sha and colleagues observed altered miRNA 
expression in stimulated IVF cycles in comparison with natural cycles, thus 
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indicating miRNA importance for obtaining endometrial receptivity (Sha et al., 
2011). Some miRNAs with altered gene expression had estrogen or progeste-
rone response elements in their promoter region, suggesting direct response of 
these miRNAs to the ovarian hormones (Sha et al., 2011). In the work of Vilella 
et al., several miRNAs showed changes in expression during WOI in 
comparison with the rest of the menstrual cycle; and were actively produced by 
glandular epithelium, then packed into EVs and secreted into the lumen of the 
endometrial cavity (Vilella et al., 2015). These small RNAs participate in oocyte 
maturation and were found in both oocyte and follicular fluid, thus they could 
mediate communication between the oocyte and somatic cells (Battaglia et al., 
2017). miRNAs are also associated with endometrial cancer development, 
where miRNA expression levels are correlating with expression levels of endo-
metrial cancer-associated genes (Boren et al., 2008). The exposure to harmful 
environmental factors is playing its role in miRNA regulated infertility and 
there has been shown, that cigarette smoke exposure induces ovarian dysregu-
lation in mice through several miRNAs (Furlong et al., 2018). In comparison 
with mRNA miRNAs are more stable and could remain intact longer periods of 
time, thus have great potential to become robust biomarkers of infertility or 
some other reproductive disorders (Robles et al., 2019). 
Sigurgeirsson et al. showed another type of non-coding RNAs – small 
nucleolar RNAs (snoRNAs), which are involved in posttranscriptional matura-
tion of rRNA and are expressed in MSE, thus may have a potential role in 
receptivity regulation (Sigurgeirsson et al., 2016). lncRNAs also influence 
endometrial receptivity, probably through competing for shared miRNAs with 
other RNA transcripts, and some of them could function as potential biomarkers 
due to maintaining stability in peripheral blood (Feng et al., 2018). It was 
shown that lncRNAs are dysregulated in RIF women in comparison to women 
who conceived after embryo transfer (Fan et al., 2017) and some lncRNAs 
could potentially target oocyte miRNAs and this way regulate oocyte 
maturation (Battaglia et al., 2017). 
With the development of new methods and technology, there is great 
potential to find other RNA types influencing the regulation of the menstrual 
cycle and reproductive health in general. Also, it has been shown, especially in 
cancer studies, that expression of miRNAs and other non-coding RNAs are 
regulated through epigenetic mechanisms such as methylation of CpG islands or 
histone modifications (Strmsek and Kunej, 2015). The epigenetic regulation of 
gene expression and their regulatory non-coding RNAs indicate the importance 
of adding new ‘omics’ layer – methylomics, for better understanding of endo-
metrial receptivity mechanisms. 
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1.7. Methylomics methods 
DNA methylation is one of the epigenetic mechanisms for gene expression 
regulation, thus it is relevant for genomic imprinting, X chromosome inactiva-
tion, cell-type-specific expression, gene silencing, suppression of repetitive ele-
ments, and alternative splicing (Gao et al., 2012; Jones, 1999, 2012; Lokk et al., 
2014; Yamagata et al., 2009). 
DNA methylation takes place when methyltransferases transfer the methyl 
group to 5’-cytosine of CpG (cytosine-guanine pair bound with phosphodiester 
bond) site, thus accumulating 5’-methylcytosine on DNA strand (Gao et al., 
2012; Jones, 1999, 2012; Laird, 2010; Oakeley, 1999; Yamagata et al., 2009). 
Previously it was shown that in bacterial cells both cytosine and adenine can be 
methylated (Noyer-Weidner and Trautner, 1993), while in eukaryotes mainly 
cytosines are methylated (Gupta et al., 2010; Harrison and Parle-McDermott, 
2011; Laird, 2010). In humans methylation usually takes place at cytosine bases 
that are followed by guanines (Bock et al., 2010; Harrison and Parle-McDermott, 
2011), thus CpG is the name of methylation site, but in embryonic stem cells 
also the non-CpG specific methylation can be found (Lister et al., 2009; Ram-
sahoye et al., 2000). The CpG sites usually aggregate to clusters in gene pro-
moter areas and are called CpG islands (CGI) (Gao et al., 2012; Jones, 1999, 
2012; Yamagata et al., 2009). The hypomethylation of such islands usually leads 
to enhanced gene expression, while hypermethylation results in gene silencing 
(Gao et al., 2012; Jones, 1999, 2012; Laird, 2010). Still, some CGIs can be found 
in the coding regions of genes or locations associated with transcriptional start 
sites, and for some genes in the gene body (the gene region between 1st exon and 
3’UTR) regions, where hypermethylation leads to increased expression levels – 
such phenomenon is called “DNA methylation paradox” (Jones, 1999; Laird, 
2010). 
 There are four methylation/demethylation types: de novo methylation, where 
previously unmethylated cytosines become methylated; methylation maintenance, 
that takes place during DNA replication; passive demethylation, when main-
tenance is suppressed during each cycle of DNA replication and DNA strand 
between methylated and unmethylated states are hemimethylated (there is a 
methylation mark on one strand and on the other one the methylation mark is 
absent); and active demethylation, when enzymes decrease methylation levels 
(Figure 9) (Oakeley, 1999). DNMT3a with DNMT3b methyltransferases are 
responsible for de novo methylation, while DNMT1 is responsible for accurately 
replicating methylation patterns during cell division thus maintaining the correct 
DNA methylation pattern in mammalian cells (Cedar and Bergman, 2009; 
Jones, 2012; Wreczycka et al., 2017; Yamagata et al., 2009). 
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Figure 9. There are four types of methylation/demethylation processes: de novo 
methylation, methylation maintenance, passive demethylation, and active demethyla-
tion. The first two and active demethylation are dependent on enzyme activity, while the 
passive demethylation occurs when methyltransferases are inactive. De novo 
methylation is mainly curated by DNMT3a/b methyltransferases, where methylation 
marks are directly added to unmethylated cytosines (green circles). Methylation 
maintenance takes place after DNA replication, where one strand is unmethylated and 
the other one has methylation patterns from replicated DNA. DNMT1 is the main 
enzyme that restores the previous methylation pattern in this scenario. If the DNMT1 is 
inactive, the passive demethylation takes place, where DNA between methylated and 
unmethylated states is hemimethylated. TET and Idh1/2 enzymes remove methylation 
marks from methylated cytosines (red circles), thus are responsible for active DNA 
demethylation. 
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Methylation processes are tissue-specific and similar tissues cluster together 
according to methylation patterns; still, as methylation is a dynamic process, it 
could be influenced by nutritional- (Liu et al., 2003), pathogenic- (Leonard et 
al., 2012), environmental (Bind et al., 2012) and age-related factors (Madrigano 
et al., 2012). The tissue-specificity according to Schroeder et al. (Schroeder et 
al., 2013) is associated with partially methylated domains (PMDs), which in 
some hypomethylated tissues, such as placenta and some cancers, could cover 
up to 40% of the genome. Genes that are located within PMDs have lower 
expression levels due to highly methylated promoters and hypomethylated other 
gene regions, which is true for hypomethylated tissues – placenta in this case, 
but not for most human tissues that are highly methylated (Schroeder et al., 
2013).  
 
 
1.7.1. Evolution of methods for studying DNA methylation 
The methods for studying DNA methylation have evolved (Figure 10) from the 
simple 5’-methylcytosine amount measurement in the genome to a variety of 
comparative methods, that were later adapted for arrays and sequencing (Gupta et 
al., 2010; Harrison and Parle-McDermott, 2011). Methods available before 2000 
were gene-specific and non-specific or genome-wide methods. The first ones in-
clude sodium-bisulfite reaction, restriction endonucleases (HpaII/MspI), ligation-
mediated PCR (Maxam-Gilbert sequencing applied), methylation-sensitive single 
nucleotide primer extension (MS-SNuPE) and combined bisulfite restriction 
methods like COBRA. The second group included reverse-phase high-perfor-
mance liquid chromatography (RP-HPLC), thin layer chromatography, SssI 
methyltransferase assay, methylation-sensitive single-strand conformation poly-
morphism analysis (SSPA) and hybridization-based methods (Fraga and Esteller, 
2002; Harrison and Parle-McDermott, 2011; Oakeley, 1999; Shen and Waterland, 
2007).  
Nowadays methylation arrays and sequencing are based on modified methods 
such as immunoprecipitation with antibodies or specific methyl-binding proteins, 
DNA cleavage with methyl-sensitive restrictases and bisulfite treatment followed 
by PCR amplification and sequencing (Gupta et al., 2010; Harrison and Parle-
McDermott, 2011; Laird, 2010; Zuo et al., 2009). While bisulfite treatment-
based sequencing is most popular among methylation sequencing methods, 
there is also a single-molecule real-time sequencing, that allows direct detection 
of DNA methylation without previous bisulfite treatment (Harrison and Parle-
McDermott, 2011; Kurdyukov and Bullock, 2016; Laird, 2010). 
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1.7.2. Methylation sequencing and  
microarray data analysis workflows 
The broad usage of arrays and NGS on big datasets increased the need for pro-
per analyzing methods and bioinformatic tools for DNA methylation data 
analysis. The methylation data analyzing methods depend on whether the data is 
array or sequencing-based. But in both cases, there are common basic steps, such 
as data normalization, exploratory analysis, and accounting for batch effects.  
For the sequenced reads, the first steps are quality control (QC) and adapter 
trimming, followed by mapping good quality reads to the reference genome, 
mapped data quality control and methylation calling. The raw read base call 
QC, adapter removal and end trimming are necessary to prevent false C-T 
conversion from miscalled bases and increase alignment rates, while the align-
ment QC helps to detect and eliminate unmethylated Cs at the end of fragments, 
incomplete bisulfite conversion, DNA degradation and PCR bias (Wreczycka et 
al., 2017). The last step is the analysis itself, where the most common option is 
differential methylation analysis on single CpG or region level. There are seve-
ral tools available for differential methylation analysis that are based on 
multiple statistical approaches such as Fisher’s test, hidden Markov models, 
linear and logistic regression-based models, and some more complex regression 
models that use beta-binomial distribution (Wreczycka et al., 2017). Some of 
the tools have several approaches to choose from, like RnBeads (Assenov et al., 
2014) and Bsmooth (Hansen et al., 2012), that use both Fisher’s exact test and 
regression models. The choice of the tool depends on the availability of replica-
tes, so regression-based tools are a good option for data with replicates, while 
Fisher’s test-based ones should be preferred for data without replicates 
(Wreczycka et al., 2017). The analysis workflow of bisulfite sequencing methy-
lation data is shown on Figure 11 A. Steps for microarray data analysis are as 
follows: QC, filtering by different parameters (single nucleotide polymorphism 
(SNP) associated, from X and Y chromosomes, multi-hits, etc.), data normali-
zation, covariate analysis, exploratory analysis, batch effect correction and 
differential methylation analysis (Figure 11 B), where most of these steps 
include visualization to help data interpretation (Assenov et al., 2014; Bock, 
2012; Morris et al., 2014). 
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Figure 11. A. Analysis workflow of bisulfite sequenced DNA methylation data. The 
first step includes base quality check, adapter removal, and read end trimming. Next is 
alignment to the genome with Bismark or some similar tool. Third – the alignment 
quality check includes removing PCR bias (could be partly fixed by removing multi-
mapped reads – deduplication and coverage filtering) and methylation calling (advised 
checking of conversion rates and filtering of known SNPs). These steps are followed by 
visualization, analysis, annotation, and interpretation of the results. Scheme based on 
Wreczycka et al. (Wreczycka et al., 2017). B. Analysis workflow of methylation array 
based on InfiniumHumanMethylation450K array example. The filtering and QC steps 
may be shifted. The QC step helps to distinguish outlier probes, for example with 
inefficient bisulfite conversion. The filtering step removes CpGs that could affect 
normalization and further analysis, such as sites located on sex chromosomes. The 
normalization is necessary to decrease technical noise and eliminate biases. Next is 
batch effect correction. Different analyses could be done after data preprocessing steps, 
where exploratory and differential methylation analyses are the most popular analyses. 
Scheme based on ChAMP (Morris et al., 2014) and RnBeads (Assenov et al., 2014) 
manuals. 
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QC of bisulfite array methylation data usually addresses bisulfite conversion 
efficiency, unspecific probe hybridization, sample sex prediction and in some 
cases sample mix-ups. The filtering step includes parameters used for probe 
filtering such as detection P-value, known SNP overlapping probes, cross-hybri-
dization probes, probes with missing values, probes on sex chromosomes, non-
CpG probes, sometimes user-defined criteria, and may be done before and/or 
after normalization, for example in RnBeads filtering is done before and after 
data normalization. (Assenov et al., 2014; Fortin et al., 2014, 2016; Morris et 
al., 2014). The array data normalization is necessary to eliminate biases and 
decrease the level of technical noise. Several within-array (SWAN (Maksimovic 
et al., 2012), BMIQ (Teschendorff et al., 2013), NOOB (Davis et al., 2019), 
PBC (Dedeurwaerder et al., 2011), etc.) and between-array (Funnorm (Fortin et 
al., 2014), Dasen (Pidsley et al., 2013), SQN (Aryee et al., 2014; Touleimat and 
Tost, 2012)) normalization methods are available (Assenov et al., 2014; Fortin 
et al., 2014; Liu and Siegmund, 2016; Morris et al., 2014; Wang et al., 2015). 
There is no golden normalization standard/method for methylation data, but 
several works compared Infinium 450K array within-array normalization methods 
and agreed that BMIQ is in general good for Infinium I/II-type probe bias 
correction (Dedeurwaerder et al., 2014; Liu and Siegmund, 2016; Wang et al., 
2018), also there were proposed combinations of several methods such as 
NOOB+BMIQ (Liu and Siegmund, 2016). 
The normalized data could be analyzed in many ways, where the most popular 
ones are exploratory and differential methylation analyses. The exploratory 
analysis gives an overview of normalized data including batch effects through 
principal component analysis, sample clustering and similarity, and global 
distribution of methylation levels, while differential methylation analysis gives a 
deeper insight of methylation levels between sample groups (Assenov et al., 
2014; Bock, 2012). The methylation is usually analyzed on a single CpG or 
region level (DMR – differentially methylated region) (Assenov et al., 2014; 
Bibikova et al., 2011; Bock, 2012; Wreczycka et al., 2017). Single CpGs could be 
clustered according to region length, or gene functionality regions (gene body – 
gene coding region excluding 1st exon; 1st Exon; TSS500/TSS200 – 500/200 kb 
upstream transcription start site; 3’ untranslated region (UTR) and 5’UTR), or 
considering their relation to CpG islands (CpG island (CGI) – a region with 
high CpG site frequency; Shore – region flanking CGI from the north (N) and 
south (S); Shelf – 2 kb regions directly adjacent to shores from N and S; and 
Open Sea – regions more than 4kb away from CGIs) (Figure 12) (Assenov et 
al., 2014; Bibikova et al., 2011; Wreczycka et al., 2017). DMRs could be pre-
defined through relation to the island or gene functionality; or through user-
defined criteria like fixed tiling window length, or fixed number of CpGs per 
region, or smoothed estimated effect sizes (Wreczycka et al., 2017). There are a 
lot of statistical models and tests available for DMR detection in array-based 
data. As was mentioned before, Fisher’s exact test is used for samples without 
replicates, Wilcoxon signed-rank test is good for not normally distributed data, 
while the paired Student’s t-test is used for paired normally distributed samples. 
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Various regression-based models (linear/logistic regression) and hidden Markov 
models (Bock, 2012; Wreczycka et al., 2017) are also used. 
After obtaining differentially methylated CpGs or regions, these need to be 
annotated, and in the case of Illumina arrays one can use the Illumina provided 
annotation file, but also files from different databases like Ensembl, or custom 
annotation files (Assenov et al., 2014). The methylation analysis may include 
gene enrichment analysis, differential methylation interaction hotspots, copy 
number variation (CNV) analysis (Morris et al., 2014) and also could be com-
bined with gene expression data to find novel expression regulatory mecha-
nisms and provide evidence for the methylational findings. 
 
Figure 12. Grouping of CpGs. Red pins – methylated CpGs, green pins – non-
methylated CpGs, and pink pins – hemimethylated CpGs. A. CpG clustering by gene 
functional regions. TSS – transcription start site, TSS200 – 200 bp upstream of TSS, 
TSS1500 – 1500 bp upstream of TSS. B. CpG clustering in relation to CpG island. C. 
CpG clustering to differentially methylated regions (DMRs) with fixed tiling window 
length. A and B are examples of pre-defined DMRs, while C is user-defined (criteria: 
fixed tiling window length, or fixed number of CpGs per region, or smoothed estimated 
effect sizes) DMRs. Figure based on Bibikova et al. (Bibikova et al., 2011) and 
Wreczycka et al. (Wreczycka et al., 2017).  
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1.7.3. Factors affecting DNA methylation analysis 
In general, factors affecting DNA methylation analysis are similar to factors 
affecting RNA analysis, such as sample donor’s lifestyle and living environment 
(even maternal environment during pregnancy (Dias and Ressler, 2014; Frank-
lin et al., 2010; Heijmans et al., 2008)); sample collection, storage and prepara-
tion, data preprocessing and analysis methods (Perrino et al., 2017). It has been 
shown that methylation is age-related (Bell et al., 2012; Zhu et al., 2018), thus 
the donor’s age could influence analysis results if not taken into account. Even 
though DNA is more stable than RNA, it also degrades in time. In the 
preparation step, the bisulfite conversion could be incomplete, leading to false 
analysis results (Assenov et al., 2014; Kurdyukov and Bullock, 2016). Also, bi-
sulfite conversion is incapable of discriminating between 5-hydroxymethyl-
cytosine (indicates the active demethylation process mediated by TET enzyme) 
and 5-methylcytosine, which can raise issues for some DNA regions (Figure 13) 
(Beck, 2010; Bock, 2012; Kurdyukov and Bullock, 2016; Wreczycka et al., 
2017). In the case of sequencing, bisulfite conversion makes amplification of 
long fragments difficult due to DNA fragmentation and makes the alignment 
step complicated due to reduced genome complexity. The bisulfite conversion 
could be avoided using direct methylation detection through the sequencing of 
unmodified DNA, for example with single-molecule real-time sequencing 
(Kurdyukov and Bullock, 2016). 
 
 
Figure 13. A. Unmethylated cytosine (C), B. 5-methylated cytosine (5mC), C. 5-
hydroxymethylated cytosine (5hmC). Unmethylated cytosine is converted with bisulfite 
treatment to uracil, which is later converted to thymine. While 5-methylated and 5-
hydroxymethylated cytosines are left intact. The distinction between 5mC and 5hmC is 
necessary, as the 5hmC indicates an active demethylation process, and thus 5hmC is 
later converted to C. 
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There are array and sequencing platforms specific issues, that are valid for all 
analyses regardless of ‘omics’ data type. Some of the issues are: unspecific 
probe hybridization could occur using arrays (Bock, 2012; Wreczycka et al., 
2017), or lane batch effect using sequencing. Analyses with big sample sets are 
prone to sample mix-ups, which could be solved using genotyping data or 
eliminated via exclusion of dubious samples during data preprocessing steps 
(Assenov et al., 2014; Bock, 2012). Both array and sequencing datasets have 
various batch effects, that are addressed during QC, normalization, and filtering 
steps (Assenov et al., 2014; Bock, 2012; Wreczycka et al., 2017). A broad 
choice of methods is available for data normalization, especially for microarrays 
(Assenov et al., 2014; Morris et al., 2014; Wang et al., 2015), where one method 
could behave better than others depending on data. As there is no golden 
method and comparative works often report contradictory results (Dedeur-
waerder et al., 2014; Fortin et al., 2014; Liu and Siegmund, 2016; Wang et al., 
2015, 2018), the user should try different methods to see which one fits the best. 
Similarly, the range of models is available for differential analysis, making the 
analysis slightly more complicated (Bock, 2012; Wreczycka et al., 2017). Like 
in RNA analysis, the tissue cell-types and biopsy cellular composition also 
affect the results. Variations in methylation levels of diverse cell types could 
cause a dilution effect and influence detected methylation levels (Houseman et 
al., 2012; Kurdyukov and Bullock, 2016; Perrino et al., 2017; Teschendorff and 
Zheng, 2017). Fortunately, this issue could be solved, using deconvolution 
techniques similar to those described for transcriptome analysis (Houseman et 
al., 2012; Teschendorff and Zheng, 2017). 
 
 
1.8. Role of DNA methylation in endometrial  
receptivity context 
The majority of methylation research is made in the cancer field, but some 
studies have also been carried out for studying the female reproductive health. 
As arrays are the most popular platform for human methylation studies due to 
their good price/data quantity ratio, the majority of methylation studies in the 
reproduction field are array-based (Zhang et al., 2014a). For example, Illumina 
HumanMethylation450K bead chip was used in Saare et al. and Maekawa et al. 
studies (Maekawa et al., 2019; Saare et al., 2016), while Houshdaran preferred 
the IlluminaHumanMethylation27K array (Houshdaran et al., 2014, 2016). The 
Maekawa and colleagues’ study is interesting, as they used three different 
methods at once: ChIP-seq (immuno-precipitation) to look into histone modifi-
cations, 450K bead chip to compare methylation patterns between cell types and 
bisulfite sequencing to validate methylation patterns of genes of interest 
(Maekawa et al., 2019). Some earlier studies of endometrial cell cultures used 
immunohistochemistry to study DNA methyltransferases (Gao et al., 2012; 
Yamagata et al., 2009) and MeDIP-seq to study endometrial carcinoma types 
(Zhang et al., 2014a). Thus, the choice of methodology depends on the study 
48 
question, where arrays are used to get an overall picture of whole-genome 
methylation profiles and their differences between physiological states, while 
other methods help to get a deeper insight of other methylation aspects.  
Although the majority of studies have focused on the role of methylation in 
the context of pathology (Fan et al., 2018; Jiang et al., 2017; Zhang et al., 
2014b), it has become clear that methylation is also involved in regulating the 
normal physiological processes related to female fertility (Gao et al., 2012; 
Koukoura et al., 2016; Maekawa et al., 2019; Mortlock et al., 2019; Saare et al., 
2016; Schroeder et al., 2013; Yamagata et al., 2009). The fact that the menstrual 
cycle affects endometrial methylation (Houshdaran et al., 2016; Saare et al., 
2016) implies that it may also play a role in endometrial receptivity. Indeed, it 
has been shown that the expression of three methyltransferases (DNMT1, 
DNMT3a, and DNMT3b) changes depending on the menstrual cycle phase 
(proliferative, early-secretory and mid-secretory) (Yamagata et al., 2009). In 
concordance with Yamagata, Gao et al. showed on mice model, that DNMT1 
and DNMT3a take part in the regulation of uterine methylation during the peri-
implantation period and DNA methylation plays an important role in deciduali-
zation of stromal cells in the implantation site during early pregnancy (Gao et 
al., 2012) although recent studies have begun to question these results (Mae-
kawa et al., 2019). 
The overlap between the results of endometrial methylation studies is small. 
This could be due to differences in experimental, technological and physiologi-
cal variability, choice of data analysis methods, and/or other factors. Recent 
studies focus more on tissue cellular composition and tissue-type-specific 
methylation patterns. Rahmioglu and colleagues looked into tissue-derived and 
experimental variability of methylation and expression profiles and showed that 
methylation profiles could be influenced by age, menstrual cycle phase, 
smoking and tissue (sub-)type (Rahmioglu et al., 2017). Mortlock et al., while 
studying methylation changes in endometrium and blood during the menstrual 
cycle, observed methylation differences only in the endometrium, underlining 
the importance of using process-/disease-relevant tissues (Mortlock et al., 
2019). In a review article Saare and colleagues speculated about endometrial 
and endometrioma tissue heterogeneity, pointing out that there are many cell 
types with cell-specific methylation profiles, that can influence analysis results 
(Saare et al., 2018). Besides, the biopsy does not only contain different cell 
types, but the proportions of cells also vary from biopsy to biopsy, resulting in a 
bias towards profiles of cells with larger proportions (Saare et al., 2018).  
From the studies mentioned above, it is clear that methylation plays its role 
in endometrial receptivity and female fertility in general. As the endometrium is 
so dynamic and complex a tissue, and as methylation patterns are tissue- or 
even cell-type-specific, new approaches for fertility studies, that could manage 
dissection of whole tissue into cell types and at the same time would not lose 
the sight of interactions between various cells, are needed. The methylation 
alone is only a piece of the puzzle and is incapable of showing the whole 
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picture, but when put together with the other pieces, it could bring us a step 
closer to the solution of endometrial receptivity conundrum. 
 
 
1.9. Integration of ‘omics’ layers 
Living organisms are very complex structures, where everything is connected, 
and every process has an impact on other processes. Some of these effects are 
slight and unnoticeable on the whole system level, while others are so drastic 
that they could lead to disease or even death. The basic scheme of DNA be-
coming a protein usually goes along the lines of DNA being transcribed to RNA 
and RNA translated to protein. But actual processes are a lot more complicated. 
For instance, if we zoom in on RNA transcription, RNA splicing for production 
of mature coding RNA comes into play, and to make things even more com-
plicated, alternative splicing can result in several mRNAs with different func-
tions, which are all transcribed from the same DNA sequence. And then there 
are non-coding RNAs with a variety of functions, playing by their own rules, 
regulating mRNA transcription and degradation, while at the same time 
influencing each other. Similar multi-layered regulation can also be observed on 
DNA and protein level 
The easiest way to solve complicated problems is to dissect them into parts, 
solve these parts separately and then put everything together. In the context of 
the current thesis, the ‘parts’ in question are different ‘omics’ data layers. Ad-
mittedly, it would be an overstatement to say that we have completely ‘solved’ 
the biological questions on single ‘omics’ levels, but we do have enough insight 
to start putting them together to get an overview of the whole functionality of an 
organism, as all processes occurring in the organism are connected and depend 
on each other (Das, 2014; Perrino et al., 2017; Xu et al., 2017). To avoid biases 
and other problems, it is better to obtain different data layers from the same 
tissue, organ or organism, if possible. Putting ‘omics’ data layers together helps 
track connections between them and get a bigger picture of processes of interest 
(Perrino et al., 2017; Xu et al., 2017). For example, DNA methylation is usually 
correlated with gene expression, as this helps to get a better understanding of 
differences in methylation, that are actually changing biological pathways and 
have an impact on current processes that take place in the tissue, organ or orga-
nism (Das, 2014; Perrino et al., 2017). Also correlating gene methylation with 
transcription level helps to identify novel transcriptional regulatory mechanisms 
(Das, 2014; Wan et al., 2015). The same is valid for the combination of several 
transcriptomic layers as coding and non-coding RNAs (Perrino et al., 2017). At 
the same time, these correlations provide additional findings, which cannot be 
obtained from studying gene expression and methylation patterns separately 
(Perrino et al., 2017; Wan et al., 2015; Xu et al., 2017). The same rules are also 
valid for genome mutations, that may affect downstream processes, and by 
adding transcriptome studies could help track down mutations with real impact 
(Xu et al., 2017). When the transcriptome is integrated with the proteome, it 
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points out how many and which mRNAs are actually translated to proteins 
(Perrino et al., 2017), because many mRNAs, especially with “broken code”, 
are degraded before translation. So, for better understanding of how complex 
phenotypes are affected by gene expression, there is a need for integration of 
other ‘omics’ layers such as genomics, epigenomics, proteomics and meta-
bolomics (Perrino et al., 2017; Xu et al., 2017). Still, the integration of more 
than two layers simultaneously is challenging with current bioinformatics tools 
(Xu et al., 2017). In recent years, several works have integrated different data 
layers in the context of female fertility studies, combining genome methylation 
with gene expression (Houshdaran et al., 2014; Maekawa et al., 2019; Rah-
mioglu et al., 2017), coding RNAs with non-coding RNAs (Furlong et al., 2018; 
Sigurgeirsson et al., 2016), or genotype with methylation (Mortlock et al., 
2019). Hopefully, these studies mark the beginning of a new and more elaborate 
approach to studying female reproductive health.   
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2. AIMS OF THE STUDY 
This study aimed to gain a better insight into endometrial biology in transition 
between early-secretory and mid-secretory phases, coinciding with the window 
of implantation, by combining an endometrial gene expression dataset with 
additional ‘omics’ data layers (endometrial cell population-specific transcrip-
tome datasets, DNA methylation, and non-coding RNA (miRNA) transcription 
datasets). 
 
The specific objectives of this thesis were as follows: 
1.  To evaluate the effects of whole tissue computational deconvolution on 
differential gene expression analysis outcome on the example of human 
endometrium.  
2.  To explore the correlation between miRNAs and gene expression datasets to 
evaluate interactions of potential endometrial receptivity mRNA marker 
genes and their associated miRNAs that were predicted based on three 
different databases. 
3.  To observe genome-wide changes in methylation during the two studied 
menstrual cycle phases and assess the correlation between methylation and 
gene expression patterns.  
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3. RESULTS AND DISCUSSION 
3.1. Effect of cellular composition on endometrial  
gene expression 
The endometrium is a very dynamic and heterogeneous tissue mainly studied 
using biopsies or in vitro cultured cells. While the biopsy studies have not taken 
into account cellular composition (possible reason of moderate overlap between 
the previous studies), the cell culture studies lack a more general view on tissue 
complexity (Hayman et al., 2006; Strell et al., 2019). Thus, an alternative is to 
use whole tissue with cellular composition adjustment (Shen-Orr and Gaujoux, 
2013). Computational deconvolution is a good method to account for the 
cellular composition of biopsies, that has been previously used for gene expres-
sion profiling in blood, tumors, and lymphoid tissues (Chen et al., 2017b; Li et 
al., 2017; Pan et al., 2017; Schelker et al., 2017). However, such an approach 
has never been used for analyzing the endometrial transcriptome.  
The goals of Ref. I were to use computational deconvolution to adjust for the 
effect of cellular composition on transcriptomic profile of endometrial biopsies, 
to compare gene expression profiles from analyses with and without cellular 
composition adjustment, and to point out highly potential receptivity biomarker 
candidate genes. 
 
 
3.1.1. Description of cohort, materials, and methods 
The study was approved by the Research Ethics Committee of the University of 
Tartu, Estonia (No 221/M-31) and Ethical Clinical Research Committee of IVI 
Clinic, Valencia, Spain (No 1201-C-094-CS). Informed consent was signed by 
all women who entered the study. 
The biopsies were obtained for early-secretory (ES or LH+2) and mid-secre-
tory (MS or LH+8) endometrium from fertile women, with at least one child, 
regular menstrual cycle (25–35 days) and normal body mass index (24.1±4.8 
kg/m2). 20 participants were from Estonia and 15 from Spain, thus 35 women 
and 70 samples in total. Samples were sequenced in 3 different sequencing 
facilities: 20 at Estonian Genome Center Core Facility (EGCUT, Tartu, Esto-
nia), 20 at the Institute for Molecular Medicine Finland (FIMM, Helsinki, 
Finland) and 30 at Lifesequencing S.L. (Valencia, Spain). The paired-end RNA 
reads were trimmed and adapters removed with Trimmomatic-0.32 (Bolger et 
al., 2014), quality filtered with FASTQ quality filter tool from FASTX-Toolkit 
v.0.0.14 and mapped using TopHat2 (Kim et al., 2013) to human genome 
version 19 (hg19) (Editorial, 2010; Guo et al., 2017). The read counts per 
transcript were obtained with the HTSeq-count script (Anders et al., 2015), 
using Ensembl human release 75 (Zerbino et al., 2018) annotation file. The read 
counts were used, as they behave better than FPKMs and are sufficient for 
differential expression analysis. Further differential analysis was performed for 
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each sample group separately, where samples were grouped according to se-
quencing center, and in two separate ways: with and without intermediate 
deconvolution step and cell proportion adjustment (Figure 14).  
 
 
Figure 14. Workflow from biopsy to significantly differentially expressed genes 
(DEGs). Endometrial biopsies were obtained from Estonian and Spanish women, and 
total RNA of whole tissues was sequenced in three different facilities, hence the 
grouping according to origin and sequencing facility: Estonian (EST1), Finnish (EST2) 
and Spanish (ESP). The single-cell samples were STRT sequenced after FACS in the 
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same facility, hence grouping according to the origin only (Estonian: EST and Spanish: 
ESP) was conducted. The whole-tissue reads were preprocessed and mapped using 
different tools: FastQC (Andrews, 2010), Trimmomatic (Bolger et al., 2014), FASTX-
tools (Hannon lab, 2009), and TopHat2 (Kim et al., 2013) separately, and single-cell 
reads were pre-processed and mapped using STRTprep pipeline (Krjutškov et al., 
2016). In both cases human genome version 19 (Editorial, 2010; Guo et al., 2017) was 
used for mapping. Transcript counts were obtained with HTSeq-count (Anders et al., 
2015) script using Ensembl human annotation file release 75 (Zerbino et al., 2018) for 
both whole-tissue and single-cell reads. The single-cell and whole-tissue count matrices 
were used to computationally estimate cell proportions of whole-tissue samples using 
DeconRNASeq software (Gong and Szustakowski, 2013). DeconRNASeq estimates the 
cell-type proportions over samples by fitting a non-negative least squares equation for 
each transcript. Further, it calculates the theoretical proportions of epithelial and stromal 
cells across the whole transcriptome. The expression level Xjk of gene j in a sample k is 
the average of expected expression level s (stromal) across the cell types sij, weighted 
by the respective cell-type proportions aki (i = 1 … N, N: the total number of cell types) 
(Adapted from: (Gong and Szustakowski, 2013)). Then the two types of differential 
expression (DE) analysis using EdgeR (Robinson et al., 2010) software were performed 
per each whole-tissue sample group: with cell proportion adjustment and without cell 
proportion adjustment. Average stroma proportions, calculated from all whole-tissue 
samples, were applied as covariates in DE analysis with cell proportion adjustment. The 
DE results for mid-secretory (receptive) endometrium of groups were meta-analyzed 
according to adjusted and non-adjusted analysis type with a METAL tool (Willer et al., 
2010). Meta-analyzed results were compared and genes with the same direction of 
regulation in all groups and with Bonferroni p-value < 2.79 x 10–6 that overlapped 
between two meta-analyses were indicated as high confidence DEGs. 
 
 
 
For the deconvolution step, the R package DeconRNASeq v.1.10.0 (Gong and 
Szustakowski, 2013) was used. There are plenty of deconvolution packages for 
blood, that usually already contain reference genes for blood cells, but there is 
no such package available for endometrium. DeconRNASeq lacks any cell-type 
references, thus works on many tissues, also it is free, locally installable and 
easy to use, therefore well suited for the task at hand. To estimate cell propor-
tions in the whole tissue, the package requires whole tissue and single-cell tran-
scription levels – in this case, CPMs (counts per million reads) were used. For 
cell-type-specific expression profiles for endometrial stromal and epithelial 
cells, we used data from the SARM project (Altmäe et al., 2017; Teder et al., 
2018), which included endometrial samples from Estonia and Spain for similar 
time-points (early secretory and mid-secretory). These cell populations had been 
sorted by FACS. For analysis, we used the STRTprep pipeline (Krjutškov et al., 
2016), up to the transcript counting step, where counting was made with 
HTSeq-count script using Ensembl human release 75. Separate counting was 
done, as there was another annotation file used in the STRTprep pipeline and it 
is important to identically annotate both datasets. The DeconRNASeq requires 
one expression profile per cell type, but the SARM dataset provided us with 19 
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stromal and 17 epithelial samples for the ES phase and 24 samples per cell type 
for the MS phase that matched with bulk-tissue samples. For the elimination of 
interindividual differences, the median expression levels per cell type were used 
for each secretory phase for downstream deconvolution. 
To evaluate the accuracy of computationally estimated proportions in endo-
metrial biopsies, we also analyzed the histological images of 9 samples per each 
cycle day (LH+2/LH+8), estimating proportions, which the two cell types 
occupied in each histology image, and calculating the Pearson correlation 
between the two calculated proportion sets. 
The differential analysis results were further meta-analyzed together using 
the sample size weighted method (based on Stouffer’s Z-score) implemented 
into the METAL tool (Willer et al., 2010). METAL is flexible and can be easily 
adapted for gene expression studies (Peters et al., 2015) despite its general 
purpose – GWAS (genome-wide association study) meta-analysis. Genes that 
overlapped between two meta-analyses were considered as most likely potential 
receptivity biomarker candidates and were compared with already known gene 
lists from previous studies, for example, the ERA genes. Some of these genes 
were also validated by M. Suhorutsenko with quantitative real-time PCR. 
 
 
3.1.2. Differentially expressed genes with and  
without cell proportion adjustment 
The number of expressed transcripts varied between 22,000 and 30,500 per 
sample. As the PCA plot (Figure 15) showed clustering according to the se-
quencing facility, we carried out three differential expression analyses with and 
without cell proportion adjustment for each sample group according to the 
sequencing center, followed by meta-analysis. This approach was used to retain 
as many samples as possible in the analysis and at the same time avoid false 
results caused by batch effects. The meta-analysis of differential expression 
analysis results provided 3,591 (1,800 up-regulated and 1,791 down-regulated) 
significantly deferentially expressed transcripts in MSE without cell-fraction 
adjustment and 1,211 (679 up-regulated and 532 down-regulated) with cell 
fraction adjustment. 
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Figure 15. The plot shows sample clustering according to the sequencing facility: 
EGCUT (EST1, pink), FIMM (EST2, orange) and Spain (ESP, blue). Unpublished data. 
 
 
The overlap between the two meta-analyses resulted in 573 up-regulated and 
373 down-regulated transcripts (Bonferroni p-value < 2.79x10–6) (Figure 16). 
The genes that lost their significance after cell-fraction adjustment are probably 
reflecting the differences in cellular composition, but not the differences in 
expression. From the other side, the genes that gained their significance after 
cell-fraction adjustment were masked by the difference in cell proportions that 
in the end summed up to similar expression between ESE and MSE in the 
analysis without cell-type proportion adjustment. We concentrated our attention 
on the overlap between two meta-analyses to eliminate possible false-positive 
genes and to be extra confident in our results. The genes common for the two 
analyses and previously reported in other receptivity studies were considered as 
highly potential receptivity biomarker candidates, in total 171 genes. Inte-
restingly, out of the 238 ERA test genes (Díaz-Gimeno et al., 2011), 112 do not 
show significant expression differences after cell fraction adjustment, thus 
indicating that these markers could reflect the uneven cellular content of the 
samples or the menstrual-cycle-specific physiological changes in the tissue 
cellular composition. 
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Figure 16. Venn diagram shows the number of significant DEGs after meta-analysis. 
The violet circle indicates results without and yellow circle indicates results with cell 
proportion adjustment, respectively. Numbers outside circles indicate the total number 
of DEGs per analysis. Bold numbers in circles indicate unique (left and right) DEGs per 
analysis and overlapping (middle) between analysis. Arrows indicate up-regulated (↑) 
and down-regulated (↓) DEGs. Adapted from Ref. I. 
 
 
As an example, the top 20, by average logFC between two meta-analyses, signi-
ficantly (Bonferroni p-value < 2.79x10–6) up- and down-regulated genes are 
shown in Table 1. The 7 out of 10 positively (PAEP, C4BPA, CXCL14, 
SLC15A1, AOX1, and TSPAN8) and 3 out of 10 negatively (GREM2, MMP26, 
and SLC15A2) expressed genes are present in the ERA test and are well known 
endometrial receptivity genes. The PAK7(PAK5), SLC26A4-AS1, SULT1C2P, 
PKHD1L1, EPPIN, ADCYAP1R1, GJB6, HAP1, C2CD4A, and IRX3 are 
missing from the ERA list. These genes are associated with signaling pathways 
(PAK7, HAP1) (Cotteret et al., 2003; Shimojo, 2008), responses to different 
stimuli (ADCYAP1R1, GJB6) (UniProtKB, 2020a, 2020b), apoptosis regulation 
(PAK7, GJB6, ADCYAP1R1) (Cotteret et al., 2003; UniProtKB, 2020a, 2020b), 
immune responses (PKHD1L1, EPPIN, HAP1) (Hogan et al., 2003; Shimojo, 
2008; UniProtKB, 2020c), cell processes such as proliferation, differentiation, 
growth, migration and communication (PAK7, ADCYAP1R1, GJB6, IRX3) 
(Cotteret et al., 2003; Scarlett et al., 2015; UniProtKB, 2020a, 2020b), and 
vesicle function or transport (C2CD4A, HAP1) (Shimojo, 2008; Warton et al., 
2004). The SLC26A4-AS1 is antisense RNA of the SLC26A4 gene, and 
SULT1C2P is a pseudogene. The processes associated with the genes mentioned 
above also take place during the transition from ESE to MSE phases and 
embryo implantation, indicating the high biomarker potential of these genes. No 
or slight changes in logFC after cellular adjustment could indicate that changes 
in gene expression were not influenced by cellular composition (Table 1), while 
significant changes indicate that gene expression levels were influenced by 
cellular composition. 
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Table 1. Top 20 (by average LogFC) significantly (Bonferroni p-value < 2.79x10–6) up- 
and down-regulated genes overlapping between two meta-analyses, where the first 10 
genes with negative average logFC are separated with a double line from the 10 genes 
with positive average logFC. “Y” indicates for yes, “N“ indicates for no, “average 
LogFC” shows average log fold change between two analyses. Unpublished table. 
 
Gene P-value 
without 
cellular 
adjustment 
P-value 
with 
cellular 
adjustment
LogFC 
without 
cellular 
adjustment
LogFC 
with 
cellular 
adjustment
Average 
LogFC 
Present 
in ERA 
test 
PAK7(PAK5) 3.9e-121 5.789e-21 -5.1713 -4.9104 -5.0409 N 
SLC26A4-AS1 5.75e-91 6.681e-14 -5.0651 -4.1699 -4.6175 N 
SULT1C2P1 3.256e-35 4.707e-17 -3.6112 -5.0962 -4.3537 N 
GREM2 1.55e-92 5.097e-26 -3.9054 -4.7435 -4.3244 Y 
PKHD1L1 3.53e-35 8.002e-17 -3.4298 -4.8355 -4.1327 N 
EPPIN 1.41e-39 2.393e-17 -3.5919 -4.5516 -4.0718 N 
ADCYAP1R1 2.377e-75 1.381e-12 -4.2652 -3.3092 -3.7872 N 
MMP26 1.013e-07 3.765e-10 -2.1720 -5.3495 -3.7607 Y 
GJB6 4.418e-28 5.388e-17 -2.8037 -4.5132 -3.6585 N 
SLC15A2 8.857e-56 5.832e-21 -3.1632 -4.1328 -3.6480 Y 
PAEP 2.44e-227 1.078e-31 8.8231 7.8935 8.3583 Y 
C4BPA 3.02e-161 7.651e-30 7.6210 6.2626 6.9418 Y 
GPX3 2.24e-184 7.726e-38 7.0251 6.4316 6.7284 Y 
CXCL14 3.5e-93 1.801e-18 7.0401 6.2944 6.6673 Y 
HAP1 2.959e-72 4.854e-17 6.3741 6.6619 6.5180 N 
SLC15A1 6e-180 3.676e-48 6.8048 6.0657 6.4353 Y 
C2CD4A 3.82e-160 2.559e-30 7.5038 5.3121 6.4080 N 
IRX3 4.51e-125 1.445e-25 6.0159 5.3905 5.7032 N 
AOX1 1.54e-177 2.478e-38 5.3500 4.9856 5.1678 Y 
TSPAN8 4.88e-89 1.232e-15 5.5485 4.7050 5.1267 Y 
 
 
 
3.1.3. Validation of cell proportions 
To understand the reliability level of computational deconvolution, additional 
evaluation of cell fraction using histological methods was made. The epithelial 
fraction estimates from 18 paired samples (9 ESE and 9 MSE) with detailed 
cycle day information were correlated by my colleague and co-author T. Laisk 
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with epithelial fractions obtained with the deconvolution method. The decon-
voluted fractions were also compared with stromal and epithelial proportions 
from histological images. The comparison was made for the eight ESE and five 
MSE samples (for some individuals, more than one image was available for 
evaluation), where proportions were calculated by measuring cell-type occupied 
areas in histological images, and then the cell type area in pixels was divided by 
whole pixel count. The histological day of ESE and MSE samples correlated well 
(r = 0.88 (95% CI 0.71–0.96), P = 1.1x10–6) with epithelial cells’ proportion from 
computational deconvolution (ESE ~35% and MSE ~54%), and thus, confirmed 
epithelial cell fraction dominance in MSE, where, on average, >50% of epithelial 
cells were seen by the time of WOI in histology preparations (Figure 17). These 
results show that computational deconvolution is a reliable method for stromal 
and epithelial (the most represented cell types in endometrium) cell fraction 
estimation in whole tissue samples, but it still needs confirmation for less re-
presented, but not less important endometrial cell types.  
 
Figure 17. Histological and deconvoluted epithelial cells’ fractions. A. Proportions of 
epithelial cells’ fractions estimated by computational deconvolution (ESE – early-
secretory and MSE – mid-secretory endometrium). B. Epithelial fractions estimated by 
histological evaluation (dark-gray) and computational deconvolution (light gray). In 
five out of six samples the estimated fractions within samples showed a similarity 
between the two methods. Adapted from Ref. I. 
 
 
Overall this study gives an overview of changes in the global transcriptome 
between early-secretory and mid-secretory phases in epithelial and stromal cell 
proportions in endometrium and points out the effects of cellular composition 
on analysis outcome, thus also emphasizes the importance of cellular adjust-
ment of whole tissue studies during differential gene expression analysis. This 
work is a good example of expression meta-analysis in the case of split datasets 
and it also shows how a combination of bulk-tissue and single-cell RNA-seq 
datasets could improve analysis results.  
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3.2. Correlation between potential endometrial receptivity 
marker genes and their associated miRNAs 
As mentioned earlier, the overlap between the results of many endometrial re-
ceptivity transcriptome studies has been modest for different reasons. To 
compile a list of genes that show most robust results across various studies, Alt-
mäe et al. undertook a meta-analysis of previous studies, using the robust rank 
aggregation method (RRA) (Kolde et al., 2012), and as a result, established a 
signature of highly putative endometrial receptivity biomarkers. As a part of this 
study, we also aimed to gain insight into the expression regulation of these 
genes by analyzing their possible regulatory miRNAs in silico and validating 
the results in two independent datasets. 
 
 
3.2.1. Description of cohort, materials, and methods 
The lists of marker genes and their associated miRNAs were obtained according 
to methods in the Ref. II. The validation of in silico found marker genes was 
performed on two datasets – the whole endometrial tissue biopsies obtained 
from 20 healthy fertile women (NOTED project) and endometrial cell-type-
specific data from 16 healthy fertile women (SARM project). Both datasets had 
paired samples for ES (LH+2) and MS (LH+8) endometrium. For whole tissue 
the miRNA and mRNA data were available. Whole tissue miRNA raw reads 
were trimmed and adapters removed with Trimmomatic-0.32 (Bolger et al., 
2014), while quality filtering was prepared with FASTX-Toolkit v.0.0.13 (Hannon 
lab, 2009). Then the reads were mapped to hg19 (Editorial, 2010; Guo et al., 
2017), annotated and counted based on miRBase v.21 (Kozomara and Griffiths-
Jones, 2014; Kozomara et al., 2019) annotation files with miRDeep2.0.0.5 tool 
(Friedländer et al., 2012). The whole tissue mRNA was preprocessed using 
Trimmomatic, FASTX-tool, and FastQC (quality control) (Andrews, 2010) and 
mapped with TopHat2 to hg19. While the cell-specific mRNA was preprocessed 
and mapped to hg19 with STRTprep pipeline v.3.0.0 (Krjutškov et al., 2016). 
Both the whole tissue and cell-type-specific dataset transcripts were counted 
with HTSeq-count based on Ensembl human release 72 (Zerbino et al., 2018). 
The edgeR (Robinson et al., 2010) software was used to obtain differentially 
expressed genes and miRNAs between two groups. The DDX52, DYNLT3, C1R 
and APOD gene expression was also validated with qPCR method. 
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3.2.2. Potential receptivity marker genes and  
their associated regulating miRNAs 
The 52 up-regulated and 5 down-regulated significant meta-signature genes 
were obtained with RRA analysis from nine published studies. The enrichment 
analysis revealed that a significant proportion of these genes is involved in 
responding to external stimuli, wounding, and different immune responses, 
while some proportion of genes was connected with exosomes and extracellular 
compartment. This is understandable since the balance between maternal im-
mune tolerance and anti-infectious protective mechanisms should be established 
in the receptive uterus to provide an implantation-favorable environment for the 
embryo (Giudice, 2004; Haller-Kikkatalo et al., 2014). 
The validation on 20 whole-tissue (endometrium) and 32 cell-type-specific 
(16 epithelial and 16 stromal) samples resulted in 52 out of 57 (48 up-regulated 
and 4 down-regulated) differentially expressed meta-signature genes for whole-
tissue samples and 43 out of 57 (39 up-regulated and 4 down-regulated) genes 
for cell-type-specific samples. 16 genes showed epithelial-specific up-regula-
tion, while four genes were up-regulated and one down-regulated only in stro-
mal cells. The overlap between the two validation sets counted 35 up- and 4 
down-regulated genes. 
The involvement of miRNAs has been previously shown for endometrial 
receptivity (Altmäe et al., 2014), implantation, and pregnancy development 
(Luense et al., 2009). The TargetScan (Agarwal et al., 2015), DIANA (Paraske-
vopoulou et al., 2013) and miRanda (Betel et al., 2010) used for miRNA target 
prediction resulted in 818 miRNAs and 1,403 potential unique binding sites for 
43 meta-signature genes overlapping between all three algorithms. The potential 
binding sites were additionally filtered by overlap with AGO-CLIP datasets 
containing experimentally determined Argonaut protein binding sites. 395 sites 
showed overlap, indicating interactions between 30 meta-signature genes and 
348 miRNAs. The expressions of these miRNAs were additionally checked in 
the miRNA-seq dataset from ESE and MSE biopsies, resulting in significantly 
correlated by logFC (ESE vs MSE) 17 miRNAs and their corresponding 9 
genes (Figure 18). The correlations were also made for ESE and MSE phases 
separately, resulting in 6 genes and 29 their corresponding miRNAs for ESE, 
and 8 genes and 49 corresponding miRNAs for MSE (9 genes and 65 miRNAs 
in total) (Figure 19). 
A most common scenario is miRNA down-regulation of gene expression 
(negative correlation), but figures 18 and 19 show that most of the miRNA-gene 
pairs are positively correlated, pointing to the up-regulation of gene expression. 
There are many possibilities of how this situation can occur: 1) miRNAs can 
up-regulate gene expression through targeting gene promoters or enhancers in 
cell nucleus (Catalanotto et al., 2016; Yang et al., 2016); 2) length of 3’UTRs of 
transcripts can vary depending on the cell cycle and embryonic development, 
and miRNA binding sites are omitted in shorter 3’UTRs, thus preventing 
miRNA binding (Chen et al., 2020; Yang et al., 2016); 3) lncRNAs could act as 
62 
miRNA sponges, competing with coding genes for miRNAs (Paraskevopoulou 
and Hatzigeorgiou, 2016; Yang et al., 2016); 4) RNA-binding proteins could 
bind to miRNA recognition sites, thus preventing miRNA binding (Vasudevan, 
2012; Yang et al., 2016); 5) miRNAs can indirectly regulate gene expression 
through other genes (Vasudevan, 2012; Yang et al., 2016); 6) miRNAs could act 
as a decoy of repressive proteins (Vasudevan, 2012); and 7) there could be diffe-
rent binding-site affinity, where partial binding could up-regulate gene 
expression (Vasudevan, 2012). As this study is limited to only 57 genes, the 
processes listed above could be the possible reason why the gene expression is 
up-regulated. Still, it is important to keep in mind that correlation does not 
necessarily point to the causal relationship between two states and could be just 
a mathematical artifact instead. Thus correlation results should be interpreted 
cautiously. 
 
 
Figure 18. Significantly correlated (p-value < 0.05) expression differences (logFC) 
between two endometrial phases (ES and MS) of 9 meta-signature genes to expression 
differences (logFC) between ESE and MSE of 17 corresponding miRNAs. The x-axis 
shows miRNA-gene pairs and the y-axis shows correlation values. Unpublished data.
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While taking into account only the genes overlapped between whole-tissue and 
cell-specific datasets, five genes and their corresponding 10 miRNAs remained 
important (Figure 20). These genes are EFNA1 (ephrin-A1), receptivity marker 
that has a possible role in embryo-maternal communication (Fujiwara et al., 
2002); SPP1 (osteopontin), a secreted extracellular matrix protein that plays role 
in implantation process (Berneau et al., 2019); DKK1 (Dickkopf WNT signaling 
pathway inhibitor 1), plays role in embryonic development (Huang et al., 2018); 
ARID5B (AT-rich interactive domain 5B), plays role in cell growth and diffe-
rentiation of Β-lymphocyte progenitors, and is WNT-signaling pathway inhibitor 
(Lahoud, 2001); and ANXA4 (annexin A4), a possible regulator of ion and water 
transport in the endometrial epithelium (Ponnampalam and Rogers, 2006). 
 
 
 
Figure 20. In silico predicted mRNA-miRNA interactions, where up-regulated mRNAs 
are in red circles and down-regulated miRNAs in green rectangles. In both datasets 
validated mRNA-miRNA pairs have bold borders. The color intensities show strength of 
up/down-regulation (FDR < 0.05) where arrow intensities indicate probability 
interactions (darker have higher probability) based on TargetScan ++ score. Adapted 
from Ref. II. 
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My role in the Ref. II publication was to put together mRNA and miRNA data 
layers in validation datasets for in silico predicted mRNA-miRNA pairs. The 
combination of two layers helps a) to find stronger evidence for already known 
marker genes for endometrial receptivity; b) to better understand the regulation 
of gene expression in endometrial tissue during the mid-secretory phase, when 
the endometrium is usually most receptive to embryo; c) to point out some 
possible causes of why endometrium is not receptive to the embryo and d) to 
find new potential receptivity biomarkers among the interacting mRNA and 
miRNA pairs. 
 
 
3.3. Methylation pattern differences between early-
secretory and mid-secretory endometrium and its 
correlation with gene expression  
Recent studies have shown that methylation patterns might change during the 
menstrual cycle and correlate with changes in gene expression (Houshdaran et 
al., 2014, 2016). However, there is still a lack of knowledge about global 
methylation changes in endometrium during the transition from early secretory 
to mid-secretory state, and of the role methylation plays in the regulation of 
gene expression during that period. To understand how changes in endometrial 
DNA methylation patterns can affect endometrial receptivity and endometrial 
gene expression, a more thorough understanding of normal endometrial methy-
lome is needed. 
The aim of Ref. III study was to characterize the methylation patterns in 
early-secretory and mid-secretory phases using genome-wide technologies, and 
using integration with RNA-seq data, to find genes with expression changes 
possibly affected by changes in methylation. 
 
 
3.3.1. Description of cohort, materials, and methods 
The study was approved by the Ethics Review Committee of the University of 
Tartu, Estonia (permission no 221/M-31). Informed consent was signed by all 
women before tissue collection and all methods were carried out following 
relevant guidelines and regulations. 
For this study the endometrial biopsies from early-secretory (LH+2) and 
mid-secretory endometrium (LH+8) were obtained from 17 healthy fertile 
women, thus in total 34 paired samples. All participants were non-smokers, had 
at least one born child and had not taken any hormonal medications at least 
three months before the biopsy. The Infinium HumanMethylation 450K 
BeadChip (Illumina, San Diego, CA, USA) was used for extracted DNA 
hybridization. RnBeads v.1.1.8 (Assenov et al., 2014) package was used for 
methylation data quality control and filtering. The RnBeads was chosen as it 
contains all the necessities for array-based methylation analysis, starting from 
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data filtering and ending with differential methylation analysis while producing 
graphical output during each step. This package also allows user to choose from 
several data normalization methods, has paired sampling possibility and explo-
ratory analysis, making it convenient and easy to use. After all preprocessing 
steps, 437,022 out of 485,577 probes remained for further analysis. The probes 
were annotated according to Illumina annotation file and contained TSS200, 
TSS500, 5’UTR, 3’UTR, 1st exon, and gene body (gene coding region 
excluding 1st exon) regions. The CGI locations as Island, S and N shore, S and 
N shelf and Open sea (isolated CpGs in the genome) were also used. The diffe-
rential methylation analysis on the site level was prepared by RnBeads, seqlm 
(Kolde et al., 2016), and Wilcoxon signed-rank test using m-values as input 
calculated with lumi (Du et al., 2008) package. Three distinct approaches were 
used to eliminate possible false-positive results and the results provided by them 
were comparable on a single CpG site level. The analysis was age-adjusted, as 
there are known effects of age on DNA methylation (Bell et al., 2012). The FDR 
(false discovery rate) < 0.05 was set as significance criteria and CpGs over-
lapping between all three analysis were considered most likely truly diffe-
rentially methylated sites, that were later used in the correlation analysis. 
The whole tissue RNA-seq dataset was used the same as in the Ref. I, 
except the number of samples for correlation analysis. Only 7 samples (14 
paired samples) overlapped between methylation and expression datasets and 
were used for correlation. Briefly about expression data: about 1 μg of endo-
metrial total RNA, extracted from the biopsies, was sequenced using paired-end 
Illumina TruSeq technology (Illumina) at Estonian Genome Center. The raw 
reads were trimmed and adapters removed using Trimmomatic-0.32 (Bolger et 
al., 2014), quality filtered with FASTQ quality filter tool from FASTX-Toolkit 
v.0.0.14, and mapped using TopHat2 (Kim et al., 2013) to human genome 
version 19 (hg19). The counts per million for further correlation analysis were 
obtained with edgeR (Robinson et al., 2010) tool. 
For cis-correlation between significantly methylated CpG β values > 0.1 
and significantly differentially expressed gene CPMs were used. Correlations 
were obtained with Spearman’s rank test and permutation p-values were calcu-
lated to evaluate the significance. The enrichment analysis was performed using 
g:Profiler (Reimand et al., 2007, 2011) and PANTHER v11.1 (Mi et al., 2016). 
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3.3.2. Differential methylation in mid-secretory vs  
early-secretory endometrium 
The study showed that for both early-secretory and mid-secretory phase about 
19% and 33% CpGs were hyper- or hypomethylated, respectively. The pairwise 
comparison with Kolmogorov-Smirnov test of genomic locations relative to 
CpG islands and functional regions showed relatively low CpG methylation 
levels in islands compared to shelves in both receptivity phases (Figure 21 A), 
while TSS1500 CpG sites were slightly more methylated than TSS200 sites in 
the promoter region (Figure 21 B). The promoter regions on average were 
slightly more hypomethylated than gene body regions, indicating that active 
genomic regions are likely to be hypomethylated to provide access to transcrip-
tion factors (Lokk et al., 2014). Overall, early-secretory and mid-secretory 
phases showed similar methylation patterns with no great magnitude changes 
(Figure 22). 
The three approaches (RnBeads, Wilcoxon, and Seqlm) used for differential 
methylation analysis resulted in 22,272 overlapping CpG sites associated with 
5,979 genes differentially methylated in mid-secretory phase (Figure 23) and 
were considered as the most likely set of truly differentially methylated sites 
and their associated genes. These sites were used in further site-level analyses 
and included both increased and decreased methylation levels in mid-secretory 
phase samples. Figure 24 shows the top 10 sites with the largest methylation 
differences between two endometrial phases. One of the top genes is ZMIZ1, 
that is significant in both site- and region-level analysis, is transcription factor 
regulator, and also regulates androgen receptor, Smad3/4 and p53 signaling 
(previously associated with endometrial receptivity (Altmäe et al., 2013; Revel 
et al., 2011)). 
The DMR analysis, where DMR region is defined as 3 CpGs within 500 bp 
window, resulted in 2,026 significant regions in mid-secretory endometrium. 
Some of the CpG sites were located in genes previously associated with endo-
metrial receptivity and embryo implantation, like PAEP, GPX3, ARID5B, and 
ANXA4. The most differentially methylated annotated sites and regions were 
located in gene bodies, a small fraction was located in promoter and other gene 
regions, while the majority of the sites and DMRs could not be annotated. By 
relation to the CpG islands, most of the sites were located in ‘Open sea’ while 
the location in the CpG islands was underrepresented.  
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Figure 21. Methylation levels (Beta), obtained with Infinium HumanMethylation 450K 
BeadChip, in early-secretory (cyan-colored left side,) and mid-secretory (orange-
colored right side) endometrium: A. by the location related to CpG island, B. by 
functional regions. The x-axis represents the location/region and the y-axis shows 
methylation level as β-value (0–1). The bean-plot width represents data distribution, the 
black line shows mean methylation level in the group and the dashed line shows the 
overall average methylation level. “Others” and “Unknown” indicate CpGs annotated to 
multiple locations and with unknown annotations, respectively. Adapted from Ref. III. 
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Figure 22. DNA methylation level and beta-density plot of endometrial genes between 
two time-points, obtained with Infinium HumanMethylation 450K BeadChip. The plot 
shows only minor methylation differences between early-secretory (LH+2, red lines) 
and mid-secretory (LH+8, blue lines) endometrium samples from 17 women (34 
samples in total). Adapted from Ref. III. 
 
 
 
 
Figure 23. Venn diagram shows the overlap between three used analysis methods: 
Wilcoxon (blue), RnBeads (red) and seqlm (green). The numbers in the circles indicate 
the amount of overlapping and unique differentially methylated CpG sites. 
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Figure 24. Top 10 differentially methylated CpGs between early-secretory (LH+2) and 
mid-secretory (LH+8) endometrium with their associated genes. The x-axis shows the 
secretory phase, y-axis shows methylation level (Beta), where colors indicate sites that 
have higher (orange) and lower (cyan) methylation levels in the mid-secretory phase. 
Adapted from Ref. III. 
 
 
3.3.3. Correlation between methylation and gene expression 
levels, enrichment and pathway analyses 
The correlation analysis was conducted between the RNA-seq dataset, where 
gene expression was evaluated in CPMs, and Illumina-annotated significantly 
methylated CpGs with absolute delta-β value > 0.1. Thus, all ‘Open sea’ sites 
were excluded from the analysis. In the end, a total of 464 genes and 531 
corresponding CpGs were used for analysis, resulting in 536 gene-CpG pairs, 
including some sites that were annotated to more than one gene. The analysis 
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resulted in 169 significantly correlated gene-CpG pairs (permutation p-value 
<0.05), where positive correlations were more prevalent in gene body regions, 
while negative ones were mainly seen in 5’UTR and 1st exon regions (Table 2), 
which is consistent with “DNA methylation paradox” when hypermethylation of 
CGIs in gene body region leads to increased gene expression levels (Jones, 
1999).  
 
 
Table 2. The number of correlated CpG-gene pairs per region. Adapted from Ref. III. 
 
Region CpG-gene 
pairs per 
region (n) 
Significantly 
correlated CpGs-
gene pairs n (% of 
total correlated) 
Positively 
correlated 
CpG-gene 
pairs n (% of 
significantly 
correlated)
Negatively correlated 
CpG-gene pairs n (% of 
significantly correlated) 
TSS1500 38 9 (23.7%) 6 (66.7%) 3 (33.3%) 
TSS200 16 4 (25.0%) 2 (50%) 2 (50%) 
5’ UTR 73 28 (38.4%) 11 (39.3%) 17 (60.7%) 
1st Exon 18 4 (22.2%) 1 (25%) 3 (75%) 
Body 353 109 (30.9%) 62 (56.9%) 47 (43.1%) 
3’UTR 48 15 (31.3%) 8 (53.3%) 7 (46.7%) 
Total 536 169 (31.5%) 90 (53.3%) 79 (46.7) 
  
 
 
The gene ontology and pathway analyses were prepared on the site and region 
levels by V. Modhukur with g:Profiler and PANTHER tools, where for site-level 
22,272 CpGs were used, corresponding to 1,464 hypomethylated and 5,196 
hypermethylated genes, that shared 681 genes because of multiple annotations; 
while region-level analysis included 1,206 hypermethylated and 275 hypo-
methylated genes in mid-secretory phase. 
The g:Profiler site level analysis showed that genes with increased methyla-
tion levels were associated with extracellular matrix organization, cellular 
signaling, and development, while genes with decreased methylation associated 
with immune response regulation, cell activation, and adhesion. The region-
level analysis showed associations with the extracellular matrix and cellular 
adhesion, which is similar to site-level analyses. The functional analysis of 
significantly correlated gene-CpG pairs resulted in genes related to extracellular 
matrix organization (TGFB3, COL42A, ADAMTS1) and immune response for 
positively correlated genes (IL1RL1, FYN, BCL3), and no enrichment was seen 
for negatively correlated genes. 
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The analysis done using the PANTHER tool was not able to detect enrich-
ment on region level, but the site-level enrichment resulted in 16 pathways, for 
example, angiogenesis, integrin signaling, Wnt signaling and GnRH receptor, 
and chemokine/cytokine signaling mediated inflammation pathways. The path-
way analysis of significantly correlated genes showed enrichment in the integrin 
signaling pathway. Some of these pathways like extracellular matrix re-
modeling, immune response, and integrin signaling are already shown to play 
an important role in endometrial receptivity and functionality, through modi-
fying maternal immunity and tissue remodeling (Ruiz-Alonso et al., 2012). 
This study provides insight into methylation pattern changes between early-
secretory and mid-secretory endometrium, additionally connecting these 
changes with changes in gene expression. Putting together two data layers from 
the same samples helps to gain a better understanding of gene regulation during 
the transition from early- to mid-secretory phase and at the same time elimi-
nates interindividual differences. The limitations of the study are relatively 
limited sample size and whole tissue biopsy without cellular decomposition, 
thus the methylation profile for distinct cell populations and validation on 
bigger datasets are highly recommended.   
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CONCLUSIONS 
The understanding of processes and mechanisms underlying endometrial recep-
tivity helps to improve the detection of pathological states related to female 
infertility and failure of infertility treatment. Using and integrating several 
‘omics’ layers could highlight possible gene expression regulatory pathways 
and interactions between data layers, narrow down lists of biomarker candi-
dates, help to find new and better biomarkers, and give a better understanding of 
underlying processes in female reproduction, putting separate pieces of the 
puzzle together. 
The main conclusions drawn from the current thesis are as follows: 
•  Variations in cell fractions could drastically influence the results of diffe-
rential expression analysis, as the expression profiles of overrepresented cell 
types could mask the expression values of underrepresented ones. Thus, it is 
important to deconvolute transcriptomic data of whole tissue biopsy samples 
and adjust the analysis by cell fractions, as biopsies have uneven amounts of 
different cell types, particularly in the case of highly heterogeneous endo-
metrial tissue. We showed that computational deconvolution provides trust-
worthy results for endometrial tissue transcriptomic analysis and could be a 
big improvement in the identification of robust endometrial receptivity 
biomarkers. 
•  Endometrial receptivity is governed by the precise interplay between a set of 
miRNAs and their target genes/transcripts as revealed by the interactions 
predicted based on three public databases and our experimental results. The 
correlations found between miRNAs and their target mRNAs allow for a 
better understanding of the expression regulation of endometrial receptivity 
biomarkers. 
•  The differences in methylation of genes between the early-secretory and 
receptive/mid-secretory endometrial phases are minor. However, the correla-
tion analysis between the epigenetic markers of certain genes and their 
expression changes required for the endometrial receptivity helps to identify 
the endometrial receptivity biomarkers, which are regulated by epigenetic 
mechanisms. These correlations between the two ‘omics’ data layers could 
give some hints of possible regulatory pathways and mechanisms for ob-
taining endometrial receptivity, as well as help to select the most robust and 
reliable biomarkers for clinical purposes.  
 
This thesis shows that integration of ‘omics’ data layers is helping to better 
understand the processes underlying endometrial receptivity, and is instrumental 
for gathering novel information, supporting already existing knowledge and 
helping to avoid false-positive results, which is currently considered as one of 
the major drawbacks of ‘omics’ approaches. The work also encourages further 
studies to integrate even more data layers, to get the best possible understanding 
of the endometrial functioning.  
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SUMMARY IN ESTONIAN 
Geeniekspressiooni andmete integreerimine teiste ‘oomika’ 
andmetega kirjeldamaks endomeetriumi retseptiivsuse 
bioloogilisi mehhanisme 
Rasestumiseks on vaja regulaarset ning korrektselt reguleeritud menstruaaltsüklit. 
Menstruaaltsükkel on jagatud erinevateks faasideks. Rasestumiseks on eriti olu-
lised endomeetriumi ehk emaka sisemise limaskesta proliferatsiooni (paksene-
mine) faas ja sellele järgnev sekretoorne faas. Sekretoorne faas omakorda jagu-
neb kolmeks alamfaasiks: varajaseks (pre-retseptiivne), keskmiseks (retseptiiv-
ne) ja hiliseks (post-retseptiivne). Varajases alamfaasis endomeetrium on jõud-
nud optimaalse paksuseni, kuid ei ole veel embrüo vastuvõtmiseks valmis. 
Keskmises alamfaasis endomeetrium on valmis embrüot vastu võtma, siis kui 
hilises alamfaasis embrüo pesastumine ei ole enam võimalik. Menstruaaltsükkel 
algab emaka ettevalmistamisega tulevase embrüo vastuvõtuks. Sellel ajal endo-
meetrium pakseneb ning umbes tsükli 14. päevaks (tavalise 28 päevase tsükli 
korral) jõuab optimaalse paksuseni. Samal päeval toimub ka munaraku ovulat-
sioon. Alates ca 20. päevast algab 48-tunnine periood ehk implantatsiooni aken, 
mille ajal endomeetrium on kõige vastuvõtlikum (retseptiivne) embrüo suhtes. 
Just implantatsiooni akna ajal toimub embrüo pesastumine emakasse. Mõlemad, 
nii endomeetriumi küpsemine kui ka embrüo pesastumine nõuavad täpselt regu-
leeritud koostööd erinevate faktorite (signaalmolekulid, valgud, RNA molekulid 
jne), rakkude ja kudede vahel. Seda kõike on võimalik uurida erinevatel bioloo-
gilistel tasemetel, näiteks genoomi struktuursed muutused (genoomika), DNA 
modifikatsioonid sh metülatsioon (epigenoomika), geenide avaldumine ja DNA 
transkriptsioon (transkriptoomika), valkude avaldumine ja nende struktuur 
(proteoomika), metaboliidid (metaboloomika). Teadusharusid, mis neid bioloo-
gilisi tasemeid uurivad, kollektiivselt kutsutakse “oomika” teadusteks. Igal 
“oomika” harul on omad uurimismeetodid, kuid enamik nendest meetoditest 
põhineb siiski sekveneerimisel (DNA järjestuse määramine) ja mikrokiibi ana-
lüüsil. Sekveneerimise ja mikrokiibi andmeid analüüsitakse erinevalt, kasutades 
selleks spetsiifilisi programmide pakette. Andmeanalüüsi programmi või paketi 
peab kasutaja valima lähtudes enda andmetest, nende päritolust ja kvaliteedist. 
Mõnel juhul on valikut teha keeruline, ning siis tuleb pakette ükshaaval läbi 
proovida, et leida nende hulgast parim lähenemisviis. Heaks näiteks program-
mide rohkusest ja sobiva programmi valikust on metülatsiooni andmete norma-
liseerimine. Kuna üks “oomika” haru uurib ainult ühte bioloogilise info taset, 
võimaldab see näha ainult terviku ühte osa. Tervikpildi nägemiseks on aga vaja-
lik erinevate “oomika” tasemete kombineerimine. 
Antud töös olen kombineerinud geenide ekspressiooni (mRNA) andmeid 
endomeetriumi koe tasemel, koos mRNA andmetega endomeetriumi rakutüübi 
tasemel; mittekodeerivate mikroRNA-de (miRNA) andmetega ja endomeet-
riumi DNA metülatsiooni andmetega, ning analüüsinud geenide metülatsiooni, 
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miRNA-de ja mRNA-de tasemete omavahelisi korrelatsioone. Läbiviidud 
uuringute eesmärgiks oli paremini aru saada, mille poolest erineb pre-retsep-
tiivne endomeetrium (varajane sekretoorne faas) retseptiivsest endomeetriumist 
(kesk-sekretoorne faas), ehk millised muutused on vajalikud, et endomeetrium 
muutuks embrüole vastuvõtlikuks. 
Endomeetriumi kude koosneb erinevatest rakutüüpidest, lisaks muutub koe 
rakuline koostis tsükli vältel pidevalt. Varasemalt on näidatud, et geenide avaldu-
mine on eri rakutüüpides erinev, ning rakutüüpide proportsioonid koeproovides 
võivad mõjutada analüüsi tulemusi, st, et enamesindatud rakkude geenide aval-
dumise muster varjab vähem esindatud rakutüüpide geenide avaldumise mustrit. 
Järelikult kajastub analüüsi tulemustes ennekõike enimlevinud rakutüübi aval-
dumise muster, mitte üldine genoomi avaldumise muster. Meie uurimisobjekti-
deks olid endomeetriumi koeproovid ning eelnevalt puudus informatsioon rak-
kude proportsioonide kohta uuritavas koes ja erinevatele rakutüüpidele iseloo-
mulik geenide aktiivsuse muster. Endomeetriumi koeproovide analüüsil on nime-
tatud probleem eriti terav, kuna kude on heterogeenne, sisaldades mitmeid 
erinevaid rakutüüpe, mis kõik täidavad kindlaid ülesandeid emaka limaskesta 
funktsioneerimisel. Koe heterogeensuse probleemi lahendamiseks kasutasime 
endomeetriumi kahe peamise rakutüübi (strooma ja epiteeli rakkude) mRNA 
andmeid selleks, et in silico lähenemise abil hinnata rakulist koosseisu meie 
koeproovides. Analüüsi tulemusena tuvastasime potentsiaalseid markergeene, 
mis võimaldavad arvestada koe rakulist koostist ning tuvastada biomarkereid, 
mille ekspressiooni muutus ei sõltu erinevate rakupopulatsioonide osakaalust. 
Antud uuringutega näitasime, et juhul, kui puudub otsene informatsioon koe 
rakulise koostise kohta, on siiski võimalik usaldusväärselt kasutada in silico 
lähenemist, mis võitab arvesse koe rakulise heterogeensuse. 
Endomeetriumi mRNA ja miRNA ekspressiooni andmeid kombineerisin 
selleks, et hinnata andmebaasidel põhinevaid miRNA-mRNA vahelisi interakt-
sioone, mille korral miRNA reguleerib oma märklaudgeenide transkriptsiooni 
taset. Oma uuringus kasutasin kolleegide poolt publikatsioonide ja andmebaasi-
de alusel koostatud nimekirjasid geenidest ja neid potentsiaalselt reguleerivatest 
miRNA-dest, mille interaktsioonid tõenäoliselt omavad olulist rolli endomeet-
riumi retseptiivsuse kujunemises. Järgneva analüüsi käigus korreleerisin antud 
geenide ja miRNA-de ekspressiooni väärtusi ning antud analüüsi tulemusena 
tuvastasin 17 miRNA-d ja 9 nendega seotud märklaudgeeni, mis on seotud 
endomeetriumi retseptiivsusega. 
Endomeetriumi DNA metülatsiooni ja geeniekspressiooni andmestike ühil-
damine aitas tuvastada, kas muutused geenide metülatsiooni mustrites kajastu-
vad geenide avaldumises. Üldjuhul põhjustab geenide promootorpiirkondade 
metüleeritus nende geenide ekspressiooni langust, samas kui hüpometülatsioon 
viib ekspressiooni tõusuni. Lisaks on tuvastatud ka ebatüüpiline epigeneetilise 
regulatsiooni mehhanism nn – “metülatsiooni paradoks”, mille puhul põhjustab 
hüpermetülatsioon geeni kodeerivas piirkonnas või transkriptsiooni alguspunktis 
antud geeni ekspressiooni tõusu. Käesolevas töös kasutasime metülatsiooni muu-
tuste tuvastamiseks kolme meetodit, selleks et eemaldada võimalikult palju 
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valepositiivseid tulemusi. Kolme meetodi vahel kattunud metülatsiooni analüüsi 
tulemusi võrdlesime geeniekspressiooni väärtustega. Korrelatsioonanalüüsi 
tulemusena leidsime 169 geeni ja vastavas geenis asetseva metülatsioonisaidi 
paari. Need geenid, mis korreleerusid positiivselt (geeni metülatsioonis ja 
ekspressiooni muutused toimuvad samas suunas) olid seotud rakkude välise 
maatriksi struktuuri ja immuunvastuse protsessidega. Varem on samuti näidatud 
nimetatud bioloogiliste protsesside seost endomeetriumi retseptiivsusega. Siiski 
jäid metülatsiooni muutused üleminekul pre-retseptiivsest faasist retseptiivse 
endomeetriumi faasi suhteliselt tagasihoidlikuks, mistõttu võib arvata, et epige-
neetiline genoomi regulatsioon mängib endomeetriumi retseptiivsuse kujune-
mises küllaltki väikest rolli. Kokkuvõtvalt näitavad antud töö tulemused, et 
“oomika” andmekihtide kombineerimine aitab paremini mõista endomeetriumi 
retseptiivsusega seotud bioloogilisi protsesse, mis ei oleks võimalik, kui kasuta-
takse ainult ühe andmekihi infot.  
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